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 Preeclampsia is a leading cause of maternal and perinatal morbidity and 
mortality, affecting 8% of all pregnancies. Currently, the only effective treatment for 
preeclampsia is the premature delivery of the fetus and placenta resulting in 
significant fetal morbidity. In early pregnancy, fetal trophoblast cells invade and 
remodel maternal spiral arteries in the uterine wall to create the high capacitance 
organ of placenta. The uterine spiral arteries in preeclampsia, however, remain 
narrow and poorly remodeled. The exact mechanisms of how trophoblast invade and 
remodel the spiral arteriole are not known, and there is a paucity of relevant 
experimental models to study the mechanisms in human pregnancy. The goal of this 
work was to develop a dynamic bioprinted placenta model and use it to determine the 
role of extracellular microenvironment in preeclampsia. We began by developing a 
  
3D placenta model that could quantify trophoblast invasion rates through bioprinting. 
Then we used decellularization techniques to isolate and established the necessary 
role of placental basement membrane protein to achieve effective trophoblast 
invasion. Finally, we used the dynamic bioprinted placenta model and found 
trophoblast impairs the flow-induced angiogenesis of endothelial cells, a process that 
plays a central role in preeclampsia. Overall, we described the significant impact of 
the extracellular microenvironment on the behavior trophoblast and/or endothelial 
cells, an area that is less investigated but appeared to be critical in the pathogenesis of 
preeclampsia. Moreover, the approach presented in this work can be used to screen 
and develop novel therapeutics and biomarkers not only for preeclampsia but also 
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Chapter 1: Introduction, Objectives and Background 
1.1 Introduction 
Preeclampsia (PE) is a leading cause of maternal and perinatal morbidity and 
mortality, affecting up to 8% of all pregnancies [6-8] and resulting in greater than 
60,000 maternal deaths worldwide per year [9]. PE significantly impacts fetal 
development, and the only effective treatment for PE is premature delivery of the 
fetus and placenta resulting in significant fetal morbidity. The placenta serves the 
critical function of fetal gas exchange, nutrition and waste removal based a high flow 
and volume, low pressure hemodynamic environment. In early pregnancy, fetal 
trophoblast cells invade and remodel maternal spiral arterioles in the uterine wall to 
create this high capacitance system. The uterine spiral arteries in PE, however, remain 
narrow and poorly remodeled. The exact molecular and cellular mechanisms of how 
trophoblast invade and remodel the spiral arteries are not known, and there is a 
paucity of relevant and suitable experimental models to study the mechanisms in 
human pregnancy. For example, human studies during pregnancy are not feasible due 
to ethical, safety and regulatory constraints. Small and large animal systems as a 
surrogate model to study PE are sometimes misleading [10, 11]. Although current 
transwell-based, in vitro models of PE have enabled important findings, these data do 
not capture the complex elements and interactions in the decidua (e.g. maternal spiral 
vasculature, heterogeneous cell populations, extracellular matrix, and biochemical 
signals) [5, 11]. These limitations are particularly noteworthy since cell migration 





1.2 Objectives   
 The overall goal of this work was to determine the role of extracellular 
microenvironment in preeclampsia using a bioprinted placenta model, which was 
accomplished through the following objectives: 
1. The first objective was to develop a 3D bioprinted placenta model. Based on 
the Young’s modulus of ex vivo term placenta, we bioprinted a 3D placenta 
model that could assess trophoblast invasion. The profile of chemotactic 
gradient was characterized both in vitro and in silico. The efficacy of the 3D 
placenta model was validated by the migratory response of trophoblasts 
towards epidermal growth factor. 
2. The second objective was to determine the effect of placental basement 
membrane protein on trophoblast differentiation and invasion. Placental 
basement membrane proteins were isolated from basal plate of human term 
placenta and incorporated into the bioprinted placenta model. The effect of 
these placental basement membrane proteins on trophoblast invasion and 
differentiation were determined by measuring the invasion rates, protein, and 
gene expressions.  
3. The third objective was to assess the impact of trophoblast on interstitial flow 
on the angiogenesis of endothelial cells. A perfusion based bioreactor and a 
3D printed chamber customized for the bioprinted placenta model were 
developed to place 3D placenta model under flow. We successfully induced 





trophoblast on angiogenesis of endothelial cells were characterized through 






















1.3 Background: Spiral Artery Remodeling, Trophoblast Invasion, and Preeclampsia 
1.3.1 Introduction 
Spiral arteries in uterine wall develop during menstrual cycle under the 
influence of progesterone [13] and, without blastocyst implantation, the spiral arteries 
regress and are ultimately lost during menstrual shedding [13]. Following embryo 
implantation, the spiral arteries progressively remodel during the first 22 weeks of 
gestation[13]. The level of remodeling correlates with trophoblast invasion, with the 
greatest trophoblast invasion and vessel transformation occurring within the central 
region of the placental bed and becoming less extensive towards the periphery [14]. 
In the most remodeled vessels, there is loss of a discrete muscle layer and the 
endothelium can be completely replaced by trophoblast [15]. At the placental 
periphery where invasion is less extensive, both trophoblasts and endothelial cells can 
be seen to co-exist within the vessel [15]. The loss of vascular cells is accompanied 
by fibrinoid deposition together with the loss of vascular function, most notably 
responsiveness to vasoconstrictors [8]. The diameter of the resulting vessels can be 
increased up to 10-fold and, as a consequence, the total blood delivered to the 
intervillous space is increased 3–4 fold with a much reduced pressure [6]. This 
increased in total delivered blood meets the increasing demands of the growing fetus 
for nutrients, respiratory gases, and for the removal of metabolic waste [6]. 
Inadequate transformation of the spiral arteries reduces the total volume of blood into 
the intervillous space and cause a hypoxic condition in the placenta. The hypoxic 
condition is thought to be the cause of a number of pregnancy-related diseases such as 





understanding of PE, little is known on how the remodeling of spiral arterioles are 
regulated at a cellular and molecular level [5]. Several mechanisms may be 
responsible for the loss of vascular cells, including migration, dedifferentiation, 
phagocytosis/autophagy and apoptosis [17]. It is likely that the maternal vascular 
remodeling is orchestrated by a combination of the above mechanisms [18].  
1.3.2 Decidualization and Trophoblast-Independent Remodeling of Spiral 
Arteries  
There are evidences suggesting that there are remodeling events of spiral 
artery taking place before the arrival of the trophoblast [19], which may be important 
for complete transformation to take place later. There are efforts aim to address these 
issues by comparing events that occur in normal and ectopic pregnancies, which 
showed that decidualization in the absence of trophoblasts leads to changes in vessel 
structure [20, 21]. These changes included endothelial basophilia, vacuolation, 
increased endothelial activation and vessel dilation [20]. However, the complete 
“physiological change” [22] required the presence of trophoblasts [21]. A proposed 
term of decidua-associated remodeling has recently to describe the remodeling of 
spiral arteries prior to the arrival of trophoblasts [23].  
The mechanisms that regulates trophoblast-independent remodeling to prepare 
for more extensive transformation that takes place following trophoblast invasion 
have been little studied [18]. The sex steroids estrogen and progesterone play a 
dominant role in regulating endometrial growth and regression [24] but it is unclear 
exactly how these hormones directly regulate either endometrial blood vessel growth 





oxide synthesis [25]. Estrogen is also known to increase vessel permeability and 
endothelial cell proliferation through increased vascular endothelial growth factor 
(VEGF) release [26]. The direct effects of progesterone on uterine vessels remain 
unclear, although it may influence vascular remodeling indirectly through its effects 
on the recruitment of immune cells such as lymphocytes, macrophages and uterine 
natural killer cells to the endometrium [18]. For example, progesterone has been 
implicated in the regulation of leukocyte trafficking indirectly through its ability to 
up-regulate stromal cell chemokine expression [27]. 
1.3.3 Trophoblast-Dependent Remodeling of Spiral Arteries  
Human trophoblasts differentiate from trophoblast stem cells along two 
pathways [6]. Villous trophoblasts fuse to form a syncytium and are bathed by 
maternal blood, whereas extravillous trophoblasts are functionally defined by their 
invasive nature [11]. The extravillous trophoblasts migrate from the anchoring villi to 
form two subpopulations. The interstitial extravillous trophoblasts invade the uterine 
wall, whereas the endovascular extravillous trophoblasts migrate along the lumen of 
the spiral artery in a retrograde manner up to the myometrial segment [17]. Why the 
extravillous trophoblasts target the spiral arteries but not vein is still under debate 
[23]. Studies have shown that venous endothelial cells express the ephrin EPHB4 and 
it is suggested that this acts to repulse invading trophoblasts [28]. Another possibility 
is that the gradients of oxygen and chemoattractant(s) from the arteries may 
contribute in this targeted invasion [5, 29]. Extracellular matrix changes in decidual 
tissue have also been observed and could also influence vessel wall structure by 






The study of human spiral artery remodeling is restricted by the availability of 
biomaterial at all stages of gestation [5, 11]. The animal models are amenable to 
manipulation at both the cellular and molecular level. However, direct extrapolation 
to the human situation is not always possible, as there are significant differences seen 
during spiral artery remodeling between human and other mammal [30]. Similar loss 
of the endothelium and overall structural re-organization of the spiral arteries occurs 
in the mouse; however, comparison of different strains of immunodeficient mice 
indicates that uterine natural killer cells play a major role in remodeling of this 
species in the absence of trophoblasts [30]. The advances in ex vivo and in vitro 
placenta models enabled by 3D bioprinting and tissue engineering, along with time-







1.4 Background: Epithelial-Mesenchymal Transition (EMT) and Differentiation of 
Trophoblast 
1.4.1 Introduction and Overview  
Epithelial-mesenchymal transition (EMT) describes the process by which an 
immotile, polarized epithelial cell undergoes biochemical changes to attain 
mesenchymal cell characteristics, which include fibroblast-like morphology, matrix 
metalloproteinase (MMP) secretion and gaining the ability to migrate and invade [31-
34]. Classic EMT events in humans include: 1) embryogenesis; 2) wound healing; 
and 3) cancer metastasis [31, 35-37]. Trophoblasts and malignant cells share many 
similar phenotypic properties including extensive proliferation, migration and 
invasion into neighboring tissues and vasculature, ability to evade the immune system 
and expression of many signaling pathways [38].  
In early placental development, trophoblasts differentiate and lose their 
organized epithelial phenotype and transition to a migratory and invasive 
mesenchymal phenotype allowing them to infiltrate into the maternal decidua and 
spiral arteries. This transition has been suggested as the 4th type of EMT [31, 37].  
However, in contrast to the environment of tumor cells, the uterine environment very 
tightly controls trophoblast behavior in a spatial-temporal manner. This is evident 
since EVT invasion is restricted to the decidua and the first third of the myometrium 
at the maternal-fetal interface in uncomplicated pregnancies. With the very tight 
controls on trophoblast migration and invasion, disruption to their tight homeostasis is 
also thought to contribute to many pregnancy pathologies. For example, shallow 





abnormal deep EVT invasion is associated with placenta accreta/increta/percreta and 
uncontrolled invasion by EVT is associated with choriocarcinoma. 
A wide diversity of EMT inducers exists. Multiple extracellular stimuli such 
as growth factors, hormones, cytokines, chemokines or cell-matrix contacts, miRNAs 
initiate signaling upon interaction with receptor tyrosine kinases (RTKs), G-protein-
coupled receptors (GPCRs), integrins or others [35]. This ultimately leads to the 
activation of critical signaling cascades such as mitogen-activated protein kinases 
(MAPKs), focal adhesion kinase (FAK), the phosphoinositide 3-kinase (PI3K)-Akt 
pathway or Janus kinase (JAK)-Signal Transducers and Activators of Transcription 
(STAT) and the whole of Wnt signaling cascades controlling a wide range of 
biological processes including proliferation, differentiation, migration and apoptosis 
[35]. Nevertheless, despite the vast range of inducers, many of the signaling pathways 
have similar end points. These inducers often promote EMT via regulation of 
downstream transcription factors. A key challenge in establishing the definitive role 
of any inducing signal of EMT is that the effects of any given EMT inducer are 
context dependent. Drawing parallels from one field of biology is often difficult, 
which requires basic research to identify and resolve these context dependent effects. 
For example, transforming growth factor β (TGF-β) plays multifunctional roles in the 
regulation of cell behavior, and is implicated in both developmental biology and 
cancer biology [37]. EMT is reported to be mainly mediated by TGF-β family 





1.4.2 Inducer of EMT: TGF-β Superfamily  
TGF-β is noteworthy for its paradoxical actions in EMT, having both 
inhibitory and stimulatory effects on cell growth. During early trophoblast invasion in 
the first trimester, the maternal plasma levels of TGF-β is downregulated [39, 40].  In 
the early stages of cancer, TGF-β acts as a growth inhibitor and tumor-suppressor; but 
in the later stages, it can act as a potent inducer of EMT. Genetic and molecular 
changes in malignant cells are thought to alter their responses to signaling molecules. 
TGF-β plays crucial roles in regulating trophoblast cell adhesion, proliferation, 
differentiation, migration and invasion at the maternal-fetal interface. TGF-β exists in 
3 different isoforms, with TGF-β1 and TGF-β2 thought to be the most important at 
the maternal-fetal interface [41]. EVTs within the placental bed express TGF-β2, 
while extracellular TGF-β1 and cytoplasmic TGF-β2 are localized within the decidua 
[41]. TGF-β1 and TGF-β2 inhibit trophoblast proliferation, migration and invasion, 
and increase formation of multinucleated cells [36]. These data suggest that TGF-β is 
an important growth factor that is secreted by the decidua and has a role in controlling 
trophoblast invasion, while protecting maternal tissues from over-invasion by 
trophoblast cells.  
1.4.3 Inducer of EMT: Tyrosine Kinase Receptor (TKR) Family Growth 
Factors 
Tyrosine kinase receptor family is another class of EMT inducer for tumor 
cells that promotes trophoblast migration and invasion. Interestingly, among tyrosine 
kinase receptor family growth factors (e.g. FGF [42], IGF [43-46], EGF [47, 48] and 





and fetal growth [50], only EGFR appears to have a direct and specific impact on 
endometrial susceptibility to implantation in vivo based on a murine EGFR-ablated 
uterus model. [51] And EGF showed reduced expression in preeclamptic human 
trophoblasts. [47]. EGF acts through the PI3K/Akt pathway, a major signaling 
component downstream of growth factor receptor tyrosine kinases that regulates 
normal cellular processes including motility, proliferation, survival and [52]. During 
early trophoblast invasion in the first trimester, the maternal plasma levels of EGF are 
elevated [53, 54]. Indeed, there are evidences that suggest EGF induces partial EMT 
of trophoblast by promoting invasion [5], increasing the abundance of MMP-9 [55], 
and upregulating expression of fibronectin [56], a known EMT inducer for mammary 
epithelial cells via the tyrosine kinase receptor [57].   
1.4.4 Conclusions  
Our current understanding of EMT in the human placenta is limited [35]. 
Trophoblasts are unique in this arena because even though they also undergo 
extensive proliferation, migration and invasion, there are mechanisms that precisely 
control these functions [36]. Determining the spatial and temporal expression of 
important EMT markers and establishing their roles in the placenta are essential to 
understanding trophoblast regulation and placental development in early pregnancy 
[36]. Trophoblast functions, particularly proliferation, migration and invasion are 
likely to be influenced by EMT regulators [31]. Furthermore, unravelling the complex 
pathways and interactions that characterize the EMT in normal placental development 
will provide important clues in our understanding of how a deregulated EMT 





1.5 Background: Recent Developments in 3D In Vitro Models to Assess Cell 
Migration 
1.5.1 Introduction  
 Cell migration is fundamental in many biological processes such as 
angiogenesis [58], wound healing [59], cancer metastasis [60], neural growth [61], 
and placental development [6]. These biological processes have significant health 
implications. For example, according to American Cancer Society, it is estimated that 
600,000 cancer-related death occur in US alone yearly and the national expenditures 
for cancer totaled to nearly $125 billion [62]. Currently, the standard procedure of 
screening for potential therapeutic drugs begins with the 2D culture-based in vitro 
tests, followed by preclinical testing using animal models, and finally to clinical 
trials. Under this procedure, only about 10% of the potential drug passed through 
clinical development [63]. Many of the drug failed in clinical trials due to the lack of 
clinical efficacy and/or unacceptable toxicity, which could be attributed to the 
unreliable data collected from the 2D monolayer culture tests where cellular response 
to drug was altered because of their unnatural microenvironment [63]. To lower the 
cost of the failed compounds/molecules, the ineffective and toxic compounds should 
be screened out as early as possible, preferably before animal testing. Therefore, 
there’s a pressing need for developing more advanced in vitro 3D migration systems 
that more realistically recapitulate the in vivo cell behaviors and provide more reliable 
results to predict clinical efficacy.  
The low cost and convenience features associated with in vitro models made 





in vitro cell migration assays are often performed in 2D culture systems with flat and 
rigid surfaces (plastic and/or membrane surfaces). Although these approaches have 
produced substantial knowledge regarding cell migration, there are several 
fundamental differences between 2D and 3D microenvironment that may influence 
cell behavior [63, 64]. For example, cells cultured in 2D often results in different 
morphology, proliferation rates, and gene/proteins expressions compare to cells in 3D 
and in vivo [64, 65]. And it has been demonstrated that cell responses in 3D cultures 
are more similar to in vivo behavior compare to 2D culture [63, 65]. Moreover, 
important properties such as matrix stiffness, fluid shear stress, surface topology, and 
spatial arrangement of biomaterials on cell migration would be difficult to manipulate 
using conventional 2D culture system [66]. As such, considerable efforts have been 
put into engineering 3D in vitro models to assess cell migration. Such 3D culture 
systems provide excellent in vitro models, allowing the study of cellular migratory 
responses in a setting that resembles in vivo environments. The goal of this work was 
to highlight the recent developments in 3D cell migration models in the following 
fields: (1) angiogenesis and wound healing; (2) cancer metastasis; (3) neural/brain 
growth; and (4) placental development. The scope of this review is limited to studies 
published in the past 10 years with emphasis with 3D migration models that 
manipulated parameters that are difficult to tune in conventional 2D culture. Based on 
the reviewed literature, we proposed three design criteria that should be considered 





1.5.2 3D Migration Models to Study Angiogenesis and Wound Healing  
Angiogenesis is the development of new micro-vessels from existing blood 
vessels, which involves proliferation and migration of endothelial cells [67]. In adults, 
angiogenesis rarely occurs except in would healing, pathological conditions and/or 
endometrium growth during menstrual cycle/pregnancy [67]. There is a strong 
interest in creating vascularized engineered tissues of clinically relevant size for 
translation [68]. Even though angiogenic effects of soluble factors such as vascular 
endothelial growth factors (VEGF) has been extensively studied, biophysical 
properties such as flow-mediated angiogenic remodeling of endothelial cells remain 
unclear. As such, Song et al. developed a microfluidic tissue analog to investigate the 
role of fluid shear forces in controlling endothelial cells migration [69]. They found 
that fluid shear stress from flowing blood attenuated sprouting of endothelial cells. 
Furthermore, positive VEGF gradients initiated sprouting but negative gradients 
inhibited sprouting, promoting instead sheet-like migration analogous to vessel 
dilation. These results there are interactions between the angiogenic cues (shear stress 
and VEGF). In another study, the effect of interstitial flow on the angiogenic response 
and phenotype of endothelial cells was investigated in a 3D microfluidic device [70]. 
The authors found that in the presence of interstitial fluid significantly facilitated  
vasculogenic organization of the microvascular network regardless of the direction of 
the flow. In contrast, angiogenic sprouting was promoted only when the directions of 
flow and sprouting were opposite while angiogenic activity was suppressed into the 





flow on angiogenetic response, a physiologically relevant yet rarely investigated and 
difficult to study in conventional 2D culture systems 
To investigate interactions between endothelial cells and stromal cells, Belair 
et al. demonstrated a strategy to model blood vessel development using a induced 
pluripotent stem cell derived endothelial cell type (iPSC-EC) cultured within 
engineered platforms that mimic the 3D microenvironment [71]. In this study, the 
iPSC-ECs yielded perfusable, interconnected lumen when co-cultured with primary 
human fibroblasts, and aligned with flow in microfluidics devices. iPSC-EC functions 
during tubule network formation, barrier formation, and sprouting were consistent 
with those of primary ECs. This study provided an alternative source of endothelial 
cells and demonstrated the importance of cell-cell interactions. In addition to 
endothelial-fibroblast interactions, Trkov et al. developed a novel micropatterned 
three-dimensional hydrogel system to study human endothelial–mesenchymal stem 
cell interactions [72]. They showed mesenchymal stem cells had strong distance-
dependent migration toward endothelial cells and supported the formation of stable 
vascular networks resembling capillary-like vasculature, emphasizing the effect of 
spatial arrangement of biomaterials on cell behavior. 
Surface topology is another regulating parameter for angiogenic response that 
would be difficult to study in 2D in vitro culture systems. Hadjizadeh et al. used 
polymer fibers that were covered with endothelial cells to induce directional 
angiogenesis in a 3D coculture system [73]. These endothelial cells-covered fibers 
were embedded in a fibrin gel, following a parallel alignment pattern, in the presence 





formed between neighboring fibers. Biomolecule-grafted fibers created a guidance 
pathway that facilitated coated endothelial cells to form lumens and, from them, 
sprouting processes [73]. In addition, Sundararaghavan investigated the effect of 
topological cues in regulating angiogenesis response of endothelial cells. Aligned 
fibers were created by electrospinning technique. When fibers were aligned 
perpendicular to a chemical gradient, cells were directed by fiber alignment and there 
was no effect of the chemical gradient. These results suggest that topographical cues 
may be more influential than chemical cues in directing cell motility and should be 
considered in material design. However, the physiological relevance of surface 
topology in vivo is unclear. 
Mechanical properties and composition of extracellular matrix play important 
roles in the migration of endothelial cells but are difficult to study using conventional 
2D platform [74]. To address this challenge, Turturro et al. developed an in vitro 
model with gradients of elastic modulus and MMP-sensitive peptides to determine 
their effects on angiogenesis of endothelial cells [74]. Aggregate invasion in gradient 
hydrogels occurred with sprout alignment observed in the direction parallel to the 
gradient while control hydrogels with homogeneous properties resulted in uniform 
invasion. This directionality was found to be more prominent in gradient regions of 
increased stiffness, crosslinked MMP-sensitive peptide presentation, and immobilized 
YRGDS concentration. In another study, the effect of the degradability of 
extracellular matrix on endothelial cells migration was investigated [75]. Trappmann 
et al. developed an 3D migration model whereby molded tubular channels inside a 





chemokine gradients within a microfluidic device. They demonstrate that matrix 
degradability switched 3D endothelial cell invasion between two distinct modes: 
single-cell migration and the multicellular, strand-like invasion required for 
angiogenesis, introducing a new parameter to tune endothelial cell migration. All 
these studies have shown that biochemical and biomechanical properties of the 
extracellular matrix significantly regulate the migration of endothelial cells, which 
would be challenging to study using 2D in vitro models. 
As demonstrated, these recently developed in vitro angiogenic models have 
successfully characterized the impact of the cellular microenvironment on migration 
of endothelial cells. However, these models often lack smooth muscle cells that wrap 
around the endothelial cells. In addition, many of these models were based on 
microfluidics. While they are useful for mechanistic studies at the cellular level, they 
are not necessary relevant in generating vascularized tissues grafts/models in 
clinically relevant size (millimeter-centimeter scale).   
 Wound Healing 
Cell migration is critical in the wound healing process, which has significant 
health implications [76]. It is estimated that there are 47.5 million cases of trauma 
cases every year with a total of $695 billion of economic burden [77]. In a recent 
study, a fibroblast migration model was 3D bioprinted using gelatin-based hydrogel 
to assess wound healing responses to in tympanic membrane perforation [78]. 
Epidermal growth factor was predicted to promote wound closure based on the 
invasion rates of a murine fibroblast cell line. This result was later validated by in 





fibroblast migration model [78]. In another study that also focused on regenerating 
soft tissue, Grasman et al. created an in vitro, 3D outgrowth assay system to mimic 
cell recruitment in vivo [79]. They used this system to investigate the effect of a 
growth factor (hepatocyte growth factor (HGF))-loaded, fibrin micro-threads on 
myoblast recruitment [79]. They showed that HGF loaded micro-threads supported 
enhanced myoblast migration. Looking at migration a relatively less explored tissue, 
Aizawa et al. developed a new hydrogel model to evaluate interactions between 
endothelial cells and retinal stem and progenitor cells [80]. They found ECs adopted 
tubular-like morphologies similar to those observed in vivo and inhibited proliferation 
and differentiation of retina stem and progenitor cells. These studies again emphasize 
the importance of spatial orientation of different cell populations and cell-ECM 
interactions in governing cell migration. 
In additional to migration models for soft tissues, other investigators 
developed 3D models to investigate cell migrations in bone injuries. Sundelacruz et 
al. developed a 3D tissue engineered bone model to determine the roles of bioelectric 
modulation in bone regeneration, contrast with the more common exogenous 
stimulation of bone using applied electromagnetic fields. They developed bone-like 
scaffold by seeding human mesenchymal stem cells on silk, and cultured under 
osteogenic conditions. A bone “injury” was created by carving out a portion of the 
differentiated bone-like scaffold, and inserted a fresh and acellular scaffold to fill the 
wound. Using this system, they identified two electrophysiology-modulating 
compounds (glibenclamide and monensin) that augmented osteoblast mineralization, 





the authors did not assess the mechanical integrity of these bone models, which is the 
primary function of bones in vivo. Also focusing on bone tissue engineering, Muerza-
Cascante et al. developed an in vitro model using 3D printed polycaprolactone (PCL) 
scaffolds to create a construct that mimics the human endosteum [81]. This 3D tissue-
engineered endosteal microenvironment supported the growth and migration of 
primary human hematopoietic stem cells (HSCs) when compared to HSCs maintained 
in 2D culture. Overall, these recently developed in vitro wound healing models 
demonstrated the relationship between cell migration with their cellular 
microenvironment. However, their relevance in predicting in vivo in wound healing 
response is limited because the effects of macrophages and other immune cells, which 
are critical in the wound healing process [82, 83], were not included.   
1.5.3 3D Migration Models for Cancer Metastasis 
Despite the significant advancements in early diagnostic and therapeutic 
regimens, the metastatic progression of tumors remains a leading cause of mortality 
in cancer patients [84, 85]. The hallmark of tumors is the ability of cancerous cells to 
disseminate and invade to distant organs [85]. The metastatic process is heavily 
influenced by the extracellular matrix (ECM) density and composition of the 
surrounding tumor microenvironment [86]. Understanding the complex mechanisms 
of tumor cell migration within conventional 2D in vitro models is challenging and 
there has been an increase in tissue engineered solutions to model the tumor 
microenvironment in 3D. 
There is a significant amount of efforts in developing 3D in vitro models to 





[62]. In one study, Carey et al. developed a 3D multicellular spheroid coculture model 
that recapitulated the cellular diversity and fully 3D cell–cell and cell–matrix 
interactions in breast cancer [87]. Their results indicated that the heterogeneous 
subpopulations within a tumor could possess specialized roles during tumor 
migration. These complex interactions among the various subpopulations of cancer 
cells within a tumor could regulate critical aspects of tumor biology and affect 
clinical outcome [87]. Recently, a new model of breast cancer was proposed featuring 
both epithelial and stromal tissues arranged on a microfluidic chip to monitor tumor 
progression [88]. Similarly of what’s been reported in vivo, they found ECM 
remodeling in terms of hyaluronic acid and fibronectin overexpression in the stroma 
compartment (modeled by fibroblasts) [88]. In another study based on a microfluidic 
approach, Hockemeyer investigated the effect of cancer-associated fibroblasts and 
endothelial cells on breast cancer cell migration [89]. They found breast cancer cells 
responded differently between normal fibroblast and tumor-associated fibroblast [89]. 
To model long-term cancer progression, Estrada et al. developed an alginate-based 
assay in which aggregates of human breast cancer cells were microencapsulated in 
alginate, either alone or in combination with human fibroblasts, and cultured for 15 
days [90]. Over the culture period, there was a reduction in estrogen receptor and 
membranous E-cadherin alongside loss of cell polarity, increased collective cell 
migration and enhanced angiogenic potential in co-cultures, which are phenotypic 
alterations typical of advanced stages of cancer [90]. These features were not 





between stromal cells and breast cancer cells play a vital role in the activation of 
breast tumors to metastasize, a biological process that would be hard to model in 2D.  
In addition to cell-cell interactions, other 3D breast cancer migration models 
were developed to investigate other microenvironmental effects. Boghaert et al. 
explored how the biophysical characteristics of the host microenvironment affected 
the proliferative and invasive tumor phenotype of the earliest stages of tumor 
development [91]. They used a 3D microfabrication-based approach to engineer ducts 
composed of normal mammary epithelial cells that contained a single tumor cell. 
Regions of invasion correlated with high endogenous mechanical stress, which 
suggests that the mechanical tone of nontumorigenic host epithelium directed the 
phenotype of tumor [91]. In addition, DelNero et al. utilized alginate-based, oxygen-
controlled 3D tumor models to study the interdependence of culture context and the 
hypoxia response [92]. Notably, they showed pro-inflammatory pathways are critical 
regulators of tumor hypoxia response within 3D environments that ultimately impact 
tumor angiogenesis, potentially providing important therapeutic targets [92]. 
Altogether, these studies on breasts cancer migration demonstrated the considerable 
impact of ECM mechanical properties and oxidative stress on breast cancer 
migration, parameters that are difficult to investigate in 2D plastic culture. 
3D colon cancer models, another common cancer especially among men [62], 
are another area under intense research. Nietzer developed a 3D colorectal cancer 
model based on decellularized porcine intestinal scaffold [93]. Colon cancer cell lines 
in their 3D colorectal cancer model showed decreased numbers of proliferating cells 





tissue generation, they assembled a bioreactor and induced a tissue-like association of 
cultured tumor cells with fibroblasts reflecting tumor biopsies [93], demonstrating the 
value of using tissue-specific biomaterials for disease modeling. Another group 
developed a 3D colon cancer model comprised of a dense artificial cancer mass. This 
model was created by partial plastic compression of collagen type I containing 
colorectal cancer cells, nested in a non-dense collagen type I gel populated by 
fibroblasts and/or endothelial cells [94]. Tumor formed spheroids which invaded the 
surrounding matrix, away from the hypoxic conditions in the core of the construct, 
demonstrating the migratory effect of oxygen gradient as observed in breast cancer 
models. In another study using a collagen-based, compartmentalized approach, 
Magdeldin showed that ECM density was associated with an altered colon cancer 
migration pattern from aggregates to epithelial cell sheets. Laminin appeared to be a 
critical component in regulating endothelial cell morphology and vascular network 
formation [95], again emphasizing the critical role of extracellular matrix on cell 
migration. 
Another type of cancer that attracted researchers to develop 3D migration 
models for is skin cancer, the largest organ in human. Okochi et al. developed a novel 
magnetic cell culture array to study interactions between fibroblast and melanoma in 
spheroid culture [96]. Using a pin-holder device made of magnetic soft iron and an 
external magnet, magnetically labeled cells on the collagen gel-coated surface were 
patterned precisely. The presence of fibroblasts significantly increased the invasive 
capacity of melanoma, and the promotion of adhesion, migration, and invasion were 





demonstrated its feasibility in their study. However, the advantage of this approach 
over microfluidics and 3D printing was unclear. Moreover, another research group 
developed a wounded and inflamed in vitro 3D melanoma model to investigate the 
use of an anti-inflammatory on melanoma invasion [97]. The tissue engineered skin 
model was based on human de-epidermised acellular dermis to which keratinocytes, 
fibroblasts and three different melanoma cell lines were added in various 
combinations. A simple incisional wound was made in the model and TNF-α and 
fibrin were added to simulate conditions of inflammation. Addition of anti-
inflammatory drugs significantly decreased invasion of A375SM skin cancer cell line. 
This is one of the few studies that investigated the role inflammatory response in 
migration of skin cancer cells.  
Altogether, these recent cancer migration models have demonstrated the 
significance of extracellular matrix and stromal cells on metastasis. The usage of 
tissue-specific ECM is interesting and should be applied in other migration models 
for other tissues. However, important features of tumors such as the heterogenous 
matrix stiffness [98], immune cells [98], and tortuous vasculatures [99] should be 
included in future cancer migration models, which would be future studies. 
1.5.4 3D Migration Models for Neural Science and Brain Development 
There are a number of emerging 3D in vitro models to investigate neuronal 
migration, a pivotal step to form a functional brain [100]. Impaired neuronal 
migration is believed to contribute the pathology of psychiatric disorders including 
schizophrenia, autism spectrum disorders and epilepsy [100]. Romano developed a 





ligand density on neurite pathfinding [101]. In this work, the authors combined 
gradient-generating microfluidic devices with 3D protein-engineered hydrogels to 
study the effect of RGD ligand density on neurite pathfinding. Neural spheroids were 
encapsulated in elastin-like polypeptide hydrogels presenting with ligands and 
exposed to a microfluidic gradient of nerve growth factor. The authors found a trade-
off between neurite extension and neurite guidance, which mimics the well-known 
trade-off between adhesive forces at the leading and trailing edges of a migrating 
cells. Continue to investigate neuronal-extracellular matrix interactions, Koivisto et 
al. developed a new biomimetic hydrogels based on gellan gum [102]. The 
crosslinked gellan gum hydrogel showed properties comparable to native brain tissue 
under physiologically relevant stress and strain. Human neuronal cells demonstrated 
biocompatibility in the gellan gum-based hydrogels. Functionalization of hydrogels 
with laminin resulted neuronal cell maturation and neurite migration, but the 
mechanism of action was unclear, which called for future study [103]. Recently, a 
novel approach combining the advantages of self-organizing organoids (e.g. 
recapitulating early developmental events) and bioengineered constructs (e.g. 
reproducibly generate desired tissue architectures) to produce guided self-
organization and cortical plate formation in human brain organoids was presented 
[104]. They modeled the distinctive radial organization of the cerebral cortex and 
allowed for the study of neuronal migration. It was elegantly demonstrated that 
combining 3D cell culture with bioengineering techniques could better replicate the 
biological processes while improving tissue integrity. In another study, an in vitro 3D 





migration [105]. Mouse spinal cord motor neurons were seeded on a collagen sponge 
populated with Schwann cells and fibroblasts. This fibroblast-populated sponge was 
intended to mimic the connective tissue supporting axon migration. The authors 
showed a vigorous neurite elongation and demonstrated the spontaneous formation of 
numerous thick myelin sheaths surrounding motor fibers after long-term culture (28 
days) [105].  
In summary, these advanced in vitro neuronal migration models enabled 
researchers to study the complex interactions between cells, extracellular matrix, and 
gradients of soluble factor - parameters that are difficult to study using conventional 
2D culture. The novel approach of combining organoid and bioengineered construct 
was promising and this hybrid fabrication approach is likely to generate biologically 
functional neuronal migration model with the required structural integrity. However, 
additional microenvironmental factors such as brain interstitial fluid, which could 
play important roles in cell-cell communication, drug delivery, and immune function 
of the brain [106], should be considered in future studies to improve the physiological 
relevance of these neuronal migration models.  
1.5.5 3D Migration Models for Placentation 
A relatively less explored cell migration phenomenon in 3D culture is 
trophoblast invasion and placental development. The formation of placenta involves 
trophoblast invasion and substantial remodeling of the maternal spiral arteries [107]. 
Impaired trophoblast invasion and remodeling of the spiral arteries has significant 
implication in preeclampsia, a leading cause of maternal and fetal morbidity and 





of trophoblast migration in preeclampsia was developed [5]. Utilizing the capability 
of 3D bioprinting and shear wave elastography, the authors developed used the 3D 
placenta model to study and quantify trophoblast migration and demonstrated a 
positive correlation between trophoblast migration rates and EGF concentration. In 
another study, Aldo et al. developed an in vitro model to evaluate endothelial–
trophoblast interaction and signaling in a 3D system [108]. Human endometrial 
endothelial cell line and first trimester trophoblast cells were co-cultured and the 
trophoblast achieved complete replacement of the endothelium. Even those both 3D 
trophoblast migration model successfully demonstrated the impact of 
microenvironment, the mechanism of actions remained unclear.  
1.5.6 Design Criteria for Fabricating 3D In Vitro Cell Migration Models 
Based on these recent developments in 3D in vitro migration models, we 
propose 3 design criteria to be considered when fabricating a 3D migration model: 1) 
inherent properties of tissue and biomaterial; 2) the microenvironmental parameter to 
be assessed; 3) scale of the tissue.  
First, one would need to appreciate and select an appropriate biomaterial(s) 
that allow for cell adhesion and migration, while mimicking the bulk mechanical 
properties of the tissue. This is important because matrix stiffness has been 
demonstrated to play a significant role in cell behavior [109]. For example, 
enzymatic-degradable hydrogel (e.g. collagen [98], gelatin [78], and fibrin [79]) 
would be a prime candidate to model cell migration in soft tissues and synthetic 
material such as polycaprolactone (PCL) [81] or poly(lactic-co-glycolic acid) (PLGA) 





these synthetic materials will need to be functionalized by inserting MMP-sensitive 
and cell adhesion protein sequences to study cell migration. The biofabrication 
approach that utilizes both hydrogel and stiff synthetic polymer was presented, which 
is likely to yield the more physiologically relevant 3D cell migration models in the 
future [112]. This approach allows cells to be encapsulated in 3D, which is similar to 
in vivo, while maintains the necessary mechanical integrity. In addition, the ability to 
monitor the movement of cells is critical in studying cell migration [113]. Although 
post processing such as histological sections can be performed, real-time observation 
using microscopy would ideal for determining the dynamic migratory responses of 
cells in the 3D microenvironments. In this regard, translucent materials such as 
polydimethylsiloxane (PDMS) used in microfluidic devices [88] and gelatin 
methacrylate [114] would likely be more suitable for real-time, in situ imaging. 
Secondly, the microenvironmental parameter that modulates cell migration 
would need to be considered before fabricating the 3D migration models. For 
example, if fluid shear stress is the parameter of interest, the migration model must be 
able to be cultured under dynamic flow. In this case, microfluidics [115] or perfusion 
based bioreactor [111, 116-118] would provide the necessary biophysical cue. On the 
other hand, if cell-ligands in extracellular matrix is the process of interest, synthetic 
polymer with defined and tunable chemical structures would be appropriate as the 
peptide chains of natural polymers are generally not well-defined [74]. Moreover, if 
the initial spatial arrangement of biomaterials is important in cell migration, one 





matrix/growth factors such as 3D (bio)printing, microfluidics, and compartmentalized 
molding technique. 
Lastly, the scale of the tissue would need to be considered. For example, if 
one is investigating angiogenesis with an intent to directly fabricating pre-
vascularized tissue for human implantation, one would avoid using microfluidics 
because human tissue is typically in millimeter-centimeter scale. Moreover, diffusion 
of nutrients would need to be considered to prevent undesired necrosis when deciding 
on a scale for the cell migration model [116], which is typically not an issue in 
microfluidic devices. Altogether, the scale of the cells migration model must be 
considered because scaling up from micrometer scale to clinically relevant scale can 
be problematic [119].   
1.5.7 Conclusions 
In this work, we have highlighted the recent developments of 3D in vitro cell 
migration models and proposed three design considerations. Even though significant  
progress in bioengineering and biomaterials has enabled investigators to study the 
impact of microenvironment (e.g. fluid flow, cell-cell interactions, extracellular 
matrix) on cell migration in 3D, the effects of immune cells, tissue-specific ECM 
[120], and patient-specific cells/ECM should be considered in future work. 
Considering the proposed design considerations, it is not surprising that microfluidic 
devices has become a popular platform technology to study cell migration as spatial 
arrangements of biomaterials and fluid flow can be relatively easily accomplished. 
However, the inherent micron-scale of these devices calls for a need to fabricate 3D 





3D bioprinting and perfusion bioreactor system can be utilized. With the 
advancement the enabling technologies (e.g. microfluidics, 3D printing, and perfusion 
based bioreactor), we believe more complex and physiologically relevant in vitro 3D 






Chapter 2: Development of the Bioprinted Placenta Model 
2.1 Introduction 
In normal pregnancy, placentation occurs by trophoblast invasion of the 
maternal spiral arteries that resides in the decidua which produces a low-resistance, 
high-flow maternal uterine circulation [6, 9, 121, 122].  The maternal decidua will 
later become the maternal side of the placenta which consist of cotyledons [123].  The 
trophoblasts will form the fetal side, which consist of the chorionic villi and the fetal 
plate [123].  In contrast, poor placentation appears to arise from interactions between 
inadequate trophoblast invasion, leading to reduced placental perfusion and oxidative 
stress resulting in the production of inflammatory cytokines [6, 9, 121, 122].  One of 
the major complications resulting from poor placentation is preeclampsia (PE), which 
is a leading cause of maternal and perinatal morbidity and mortality affecting 3 to 8% 
of all pregnancies [6, 9, 107, 121, 124].  Complications of PE include preterm 
delivery, cerebrovascular accidents, liver rupture, pulmonary edema, and acute renal 
failure that can result in maternal death [6, 9, 107, 121, 124-126]. The pathogenesis of 
preeclampsia remains poorly understood and no effective treatment is available today 
other than premature delivery of the fetus and placenta [9].  The lack of effective 
experimental models has been the major obstacle to understanding the pathobiology 
of PE [11, 15, 127].  The current paucity of clinically relevant experimental models 
impedes efforts to identify prognostic indicators and potential effective treatment 
options [6, 11, 107, 121].  For example, any clinical testing on pregnant mothers is 
often not feasible due to ethical and regulatory constraints.  Animal models used to 





humans is very different from those of other species [11, 127].  Although researchers 
have been using in vitro models of PE, these models are often based on transwell 
membranes and therefore do not recapture the complex elements of the maternal 
decidua (growth factor-secreting maternal spiral vasculature, heterogeneous cell 
populations, extracellular matrix (ECM), and biochemical cues) [11].  This limitation 
is particularly noteworthy since these complex elements are critical to the 
development of PE [6, 9, 107, 121, 124].  
Extrusion-based bioprinting is a subclass of additive manufacturing that 
involves the organized and specific placement of cells, biomaterials, and biochemical 
factors to recreate complex natural tissues and organs with micro-scale resolution 
[128].  The possibility of combining different cell types and biomaterials makes 
bioprinting particularly attractive for placental tissue engineering because the tissue is 
highly complex.  Gelatin methacrylate (GelMA) is a natural inexpensive protein 
derived from hydrolysis of collagen which is highly biocompatible and biodegradable 
through enzymatic degradation and can be used for cell encapsulation[129-132].  
With a reversible thermoplastic transition occurring around 20-30°C at 5-10 w/v %, 
GelMA is an ideal candidate for bioprinting[129, 133].  Gelatin can also be 
engineered for sustained drug release by tuning its electrostatic charges at 
physiological conditions [133].  To fabricate a biomimetic 3D model of the placenta, 
we must characterize the biophysical properties of the placenta. However, the 
dynamic mechanical properties of soft tissues such as the placenta are challenging to 
quantify.  Previous studies on mechanical properties of biological tissues, such as 





properties can be developed by applying curve-fitting techniques to experimental data 
obtained through conventional mechanical test techniques (e.g. dynamic mechanical 
testing (DMA)).  However, this approach often requires the testing specimen to be 
uniform with a known geometry, which is difficult to achieve with placental tissue as 
its mechanical properties are inherently heterogenous [136].  Shear wave 
elastography (SWE) based on diagnostic ultrasound has emerged to be a powerful 
imaging technique for characterizing complex tissues and differentiating between soft 
and stiff tissues [8, 137, 138] that has several advantages over conventional 
mechanical testing techniques such as DMA.  For example, measurements done by 
SWE are independent of the geometry of the specimen [8, 138].  Moreover, in 
contrast with conventional mechanical testing techniques, SWE can distinguish 
between hard and soft regions of a single specimen in a simple, rapid and minimally 
invasive manner which would allow real-time, not only ex vivo scans but also in vivo 
scans [8]. 
To this end, we hypothesized that a bioengineered placenta model (BPM) that 
captures the essential features of the decidua to model trophoblast invasion, particularly the 
tissue’s ECM composition and mechanics as well as its growth factor-secreting vascular 
network, can be utilized to measure the effects of biochemical factors on trophoblast 
migration rate.  We tested our hypothesis through the following three objectives.  Our first 
objective was to characterize the biophysical properties of the placenta using SWE and 
develop a 3D printing platform that is able to recreate those properties.  In addition, we 
confirmed that our bioprinting platform allows us to recreate the spiral geometry of the 
maternal vasculature through our 3D printing platform in vitro.  The second objective was to 





Lastly, we aimed to test the efficacy of the BPM by evaluating the effect of epidermal 
growth factor (EGF) concentration on the migratory response of two types of cell 
populations that are present in the placenta (trophoblasts and human mesenchymal 
stem cells (hMSCs) [139, 140]).  EGF was selected because the EGF family has been 
shown to play a major role in decidualization of the endometrium as well as the 
implantation and invasion of blastocysts by activation of the intricate signaling and 
transcriptional networks [141].  To accomplish these objectives, we first determined 
the stiffness of ex vivo placenta using SWE and developed a bioprinting platform 
based on GelMA.  We then formulated our GelMA-based bioink to yield constructs 
with stiffness resembling that of ex vivo placenta.  To ensure nutrients can diffuse 
through BPM, we used glucose as a model for nutrients and calculated its 
concentration profile.  By studying the migratory behavior of BeWo cells, a 
trophoblast cell line that is widely used to study trophoblast migration[11, 29], in 2D 
and developing another diffusion model of EGF through GelMA, we decided on two 
EGF loading levels that are able to induce BeWo migration.  We finally validated the 
efficacy of our placental model by successfully quantifying the 3D migration rates of 
trophoblast and hMSCs.  To our knowledge, this BPM is the first in vitro placenta 
model that would enable study of the pathobiology of preeclampsia and development 
of novel treatment options.  Even though the BPM presented here is a simplified 
model, it will serve as a significant step towards fabricating a more complex 







2.2 Materials and Methods 
Cell Culture 
BeWo cells were purchased from ATCC and cultured in Kaighn’s 
Modification of Ham’s F-12 Medium (F-12K; ATCC) with 15% (vol/vol) Fetal 
Bovine Serum (FBS; Thermo Fisher Scientific) and 1% penicillin/streptomycin 
(Pen/Strep; Thermo Fisher Scientific).  Human mesenchymal stem cells (hMSCs) 
were kindly provided by Dr. Patrick Hanley of Children’s National Health System.  
hMSCs were grown in high-glucose Dulbecco's Modified Eagle Medium (DMEM; 
Thermo Fisher Scientific) supplemented with 10% (vol/vol) FBS and 1% 
penicillin/streptomycin. All hMSCs used in this study were passage 5 or below. 
 
Shear Wave Elastography & Ex vivo Placenta 
A clinical diagnostic ultrasound system was used to quantify the mechanical 
properties of the ex vivo placenta and in vitro 3D printed GelMA construct.  
Specifically, SWE was performed using Aixplorer ultrasound system (Supersonic 
Imagine, Aix-En Provence, France) with a linear array transducer (SL 15-4), with 50 
mm footprint and 256 elements. Duplex real-time SWE and b-mode imaging of the ex 
vivo placenta and GelMA were performed. The SWE window was placed on a portion 
of the placenta and the Young’s modulus was measured within the window as heat 
maps (high (red) to low (blue) Young’s modulus). Quantitative results of the Young’s 
modulus will be measured by placing region of interest (ROI) within the window. The 
quantitative values of average Young’s moduli in these ROIs were obtained and 





MedStar Washington Hospital Center.  All placentas were de-identified following the 
protocol IRB-2015-131 approved by the MedStar Research Institute Institutional 
Review Board.  
 
Gelatin Methacrylate Synthesis 
Gelatin methacrylate was synthesized according to previously published 
methods [129-131].  Briefly, Type A porcine skin gelatin (Sigma-Aldrich; 300 
bloom) was mixed at 10% (w/v) into phosphate buffered saline (PBS; Thermo Fisher 
Scientific) at 50 oC for 20 minutes.  Methacrylic anhydride (MA, Sigma-Aldrich) was 
added at the ratio of 0.6 g MA/g gelatin under rigorous stirring for an hour.  The 
reactants were then diluted 2x with PBS to stop the reaction.  The mixture was 
centrifuged, and the pellet was discarded.  The supernatant was dialyzed against 
deionized water using dialysis cassettes (10kDa MWCO, Thermo Fisher Scientific) 
for at least 3 days at 50°C to remove salts and excess methacrylic acid.  The dialyzed 
GelMA was then lyophilized and kept at -80°C for long-term storage. 
 
Nuclear Magnetic Resonance 
The degree of methacrylation was quantified using nuclear magnetic 
resonance (NMR) according to a previously described method [129, 132, 142].  
Briefly, the composition of acid-treated porcine skin gelatin used for analysis of 1H 
NMR data was acquired from previously published data.  Spectra were collected at 
50°C in deuterium oxide (Sigma) at a frequency of 600 MHz using a Bruker BioSpin 





2D Migration Study of BeWo Cells 
To characterize the migratory behavior of BeWo cells in 2D, the surfaces of 
glass bottom dishes were treated with fibronectin (100 μg/mL; FN) from bovine 
plasma (Sigma) for an hour.  BeWo cells were then seeded on top of the FN treated 
glass bottom dishes under different concentrations of recombinant epidermal growth 
factor (0-100 nM; EGF; Corning).  Videos were then acquired using a fluorescent 
microscope over 20 hours with environmental chamber capable of humidity, 
temperature and CO2 control.  Image J software was used to trace the movements of 
BeWo cells every 10 minutes to quantify migration rate.  BeWo cells were assumed 
to be moving linearly within the 10 minutes. 
 
Diffusion Studies 
Texas-Red-tagged EGF (Life Technologies) was mixed with the prepolymer 
(GelMA + photoinitiator) solution at a final concentration of 0.7 μM, and printed in 
the center of 3D printed GelMA constructs.  Time-lapse fluorescent microscopic 
images were taken every 15 minutes for 6 hours to examine the diffusion of EGF 
within GelMA.  The fluorescence intensity map was obtained by Image J software.  A 
standard curve was created to convert intensity values to EGF concentration.  
Intensities were obtained starting from the edge of the circular EGF source (interface 
between EGF-loaded and EGF-free GelMA at time = 0) to a distance 700 μm from 







Diffusion models of EGF and Glucose in GelMA 
The diffusion model developed in this study was based on the diffusion 
equation assuming 1D radial diffusion in cylindrical coordinates. For diffusion of 
EGF, we assumed a perfect source from the center of the disc and a no flux condition 












;  CEGF=0 µM @ t=0;  CEGF=13 µM @ r=0; 
𝜕𝐶𝐸𝐺𝐹
𝜕𝑟
=0 @ r=1 
For diffusion of glucose, we assumed a perfect source at the edge of disc from 













; Cgluc=0 µM @ t=0;  Cgluc=6 mM µM @ r=1; 
𝜕𝑔𝑙𝑢𝑐
𝜕𝑟
=0 @ r=0 
COMSOL and MATLAB were used to solve the partial differential equation 
to obtain the concentration profiles, which are then numerically integrated to obtain 
mass diffused as a function of time and position. Various mesh sizes were tested to 
ensure the computational model converges with stable output. This is demonstrated 
by the smooth curves and heat maps in Figure 2.5 and 2.6. The diffusion coefficient 
of EGF in GelMA was calculated to fit the raw data by minimizing the mean squared 
error between modeled and experimental results. The diffusion coefficient of glucose 
in GelMA is obtained from the literature [143].  
Analytical solutions are available for this model, which is provided below as 











; C= Co @ t = 0; 
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𝑚=1 ;  
Jn= Bessel function of the first kind with nth order 
While analytical solution exists for our model, we decided to move forward with 
computational fluid dynamics for its convenience.  
 
Swelling Ratio  
To determine the swelling ratio, 3D-printed GelMA discs were incubated in 
PBS overnight at 37°C to completely swell the gel.  After incubating in PBS, the 
mass of the swelled GelMA constructs were measured to obtain the wet mass.  The 
swelled GelMA constructs were then dried in an oven at 50°C for at least 72 hours 
and weighed to obtain the dry mass.  The swelling ratio was calculated using the 
formula swelling ratio = (wet mass – dry mass)/wet mass. 
 
Dynamic Mechanical Analysis 
Dynamic mechanical testing was carried out using a Q800 DMA testing 
machine.  To determine the Young's modulus of printed GelMA, cylinders 10 mm in 
diameter and 2 mm in height were fabricated using an extrusion-based bioprinter (3D-
Bioplotter; EnvisionTEC; Germany).  This size was chosen to reduce the fabrication 
time to ensure that the hydrogels did not dehydrate during the printing process.  In all 
cases, the hydrogels were treated with a preload of 0.001 N prior to mechanical 
testing.  For DMA testing, samples were tested using a strain sweep with a fixed 






Bioprinting of Simplified, Cell-laden Bioengineered Placenta Model 
All bioprinting work was completed using an extrusion-based bioprinter (3D-
Bioplotter; EnvisionTEC; Germany).  To prepare the prepolymer solution, 
lyophilized GelMA was dissolved in PBS at 50°C for 10 minutes.  Photoinitiator (2-
hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone; Irgacure 2959; BASF) 
was then added into the GelMA solution at a concentration of 0.1% (w/v) at 50°C for 
15 minutes.  The prepolymer solution was loaded into the low-temperature printer 
head and allowed to equilibrate for 30 minutes at a desired temperature.  Additional 
biomaterials such as ECM, cells, and/or growth factors of interest were added at this 
point, and the functionalized prepolymer solution was incubated for another 30 
minutes prior to printing.  Printed constructs were UV-cured for 30 seconds (0.09 
mW/cm2) using a UV box (VWR).  A calcein-AM/ethidium homodimer, Live/Dead 
assay (Life Technologies) was used to assess cell viability within printed constructs 
according to the manufacturer’s instructions. 
 
Cell Migration Studies 
BeWo cells were encapsulated in GelMA-FN to print the cylindrical 
bioengineered placenta model at a concentration of 107 cells/mL.  For the migration 
experiments, cells were printed along the periphery of the cylindrical bioengineered 
placenta model and EGF was printed in the center (Figure 2.1).  Cells were cultured 
in growth media with low serum concentration (5%) and phase-contrast images were 





bioengineered placenta model and the migration front was measured and averaged 
over time to obtain migration rates.  
 
Statistical Analysis 
Data from all the studies were analyzed using ANOVA and multiple 
comparison tests using MATLAB.  A significance level of 95% was chosen, and a p-









Figure 2.1:  Bioprinted Placenta Model. This simplified placenta model was based 
on a cylindrical GelMA hydrogel loaded with varying components at different radial 
positions. A ring of trophoblasts was encapsulated and printed along the periphery of 
model (green). A chemoattractant, EGF, was printed in the center (red) of the 
construct, and diffused outwards and thus established a radial concentration gradient. 
Due to this concentration gradient, trophoblasts migrated towards the center.  (a) Top 













2.3.1 Development of a GelMA-based Bioprinting Platform 
We began developing our bioprinting platform by synthesizing GelMA.  
Specifically, type A porcine gelatin was reacted with methacrylic anhydride at 0.6 g 
MA /g of gelatin.  The number of methacrylate groups was verified by 1H NMR and 
showed a degree of substitution of 63.1 ± 5.75% (Figure 2.2a).  We then formulated 
our bioink by mixing GelMA (5 or 10% (w/v)) with Irgacure 2959 (0.1% (w/v)), and 
optimized the bioprinting parameters to maximize resolution (Figure 2.2b,c).  Due to 
its higher viscosity, 10% GelMA hydrogel was printed at a higher pressure and 
temperature compared to those of 5% GelMA  (28 oC vs. 23 oC, 0.7 bar vs. 0.5 bar, 
respectively).  In addition, the strands produced by 10% GelMA are also slightly 
larger than those produced by 5% GelMA, which reuslts in higher layer thickness and 
interstrut distances to create solid constructs.  We also demonstrated our ability to 
print solid structures (Figure 2.2d) and spiral patterns using a blue dye (Figure 2.2e-
h).  In addition, the swelling ratio of GelMA was investigated, wherein all were 
greater than 0.95 with no significant differences between 5% and 10% GelMA (data 
not shown).  Furthermore, we measured the Young’s modulus of our 3D printed 
GelMA with 5% and 10% GelMA concentrations through dynamic mechanical 
analysis (DMA), which were 5.35 ± 0.66 kPa and 7.74 ± 0.26 kPa respectively 
(Figure 2.2k).  We also measured the stiffness of 5% GelMA using both SWE and 
DMA (Figure 2.2k) and demonstrated no significant differences between the two sets 
of collected data.  However, when we performed multiple comparison tests between 





significant differences between 5% and 10% GelMA.  Therefore, we decided to move 
forward with 5% GelMA because the stiffness is within the same order of magnitude 







Figure 2.2: Characterization of GelMA Printing Platform and Ex Vivo  
Placental Tissue.  (a) NMR results for gelatin methacrylate (n = 3). Successful 
methacrylation was confirmed by the peaks at around 5.7 and 5.9 ppm (top, red box), 
which does not appear in NMR results for gelatin control (bottom). (b,c) Lattice 
structures with 1×1mm spacing. (d) Solid disc structure (D = 10 mm). (e) CAD 
model for spiral (height: 10 mm, channel diameter: 1mm, pitch: 3 mm, taper helix 
angle: 20o, 3 revolutions. (f) Overall CAD model used for 3D printing: spiral 
embedded in a cube. (g) 3D printed spiral (blue) in a cube (transparent): side view.  
(h) 3D printed spiral (blue) in a cube (transparent): cross-sectional view. (i) 
Transverse imaging plane of a term placenta. The rectangular box represented the 
stiffness within the region where blue represented relatively soft tissues and red 
represents relatively stiff tissues. The solid (cotyledons) white and dotted (chorionic 
villus) circle represented ROI based on the anatomy of the placenta, with mean elastic 
modulus measured as 12 kPa and 43.9 kPa, respectively. (j) The transverse imaging 
plane of a printed GelMA disc (similar to Figure 2d). The rectangular box 
represented the stiffness within the region where blue represented relatively soft 
tissues and red represented relatively stiff tissues. (k) Elastic modulus of ex vivo 
placental tissue (n = 3) and 3D Printed GelMA (n = 6). Error bars indicated standard 







2.3.2 Characterizing the Diffusion of Epidermal Growth Factor (EGF) and Glucose in 
Bioprinted Placenta Model 
To decide on the type and dosage of soluble factors and ECM that should be 
printed to functionalize our BPM, we performed time-lapse microscopy of BeWo 
cells on fibronectin (FN)-coated glass treated with different concentration of EGF (0-
100 nM) for 20 hours (Figure 2.3).  Our results demonstrate that the BeWo cells 
migration rate increases in response to higher EGF concentration in a dosage-
dependent manner on 2D FN-coated glass (Figure 2.3e).  Based on these results, we 
decided on the range of EGF concentrations between 0-100 nM to be used in our 
BPM.  In addition, we decided to infiltrate the BPM with fibronectin (50 μg/mL), an 
ECM protein that is highly expressed in the placenta [144].  To verify that a 
chemotactic gradient of EGF can be established to induce chemotaxis of BeWo cells, 
we characterized the diffusion of EGF through the 3D printed GelMA.  Over the 
course of 6 hours, red fluorescent EGF emanated from the perimeter of the inner 
circle providing a spatial gradient field over the micrometer-size scale (Figure 2.4a-
d). Using a standard diffusion equation, we constructed a model that estimates the 
mass of EGF diffused as a function of time using MATLAB.  The diffusion 
coefficient of EGF in GelMA was calculated to be 2.5 ×10-8 cm2/s, which was done 
by minimizing the mean squared error between the predicted and experimental results 
(Figure 2.4f).  We then used the optimized diffusion coefficient to model the 
concentration profile of EGF in GelMA at different time points which demonstrates 
that the concentration gradient between the EGF source and the cells remains 





migration results, we decided to use a loading level of 6 and 13 μM EGF for 
subsequent studies.  As shown in Figure 2.5c, we expected the BeWo cells to sense 
the presence of EGF by Day 3, when the local EGF concentration along the edge of 
the disc where the cells are located had reached our regime of interest (0.1 µM) as 
determined in 2D migration results.  To ensure the cells embedded in the BPM 
receive sufficient nutrients, we have modeled the concentration profile of glucose in 
GelMA at different time points (Figure 2.6b).  The diffusivity of glucose in hydrogel 
was obtained from the literature [143].  Our results demonstrate that the glucose 
concentration will be homogenous in BPM by 32 hours while there is still a 
























Figure 2.3: 2D Characterization of the Effect of EGF on the Migratory Behavior 
of BeWo cells.  (a-d) Representative microscopy images of BeWo cells with 100 nM 
of EGF in the media. Cells appeared to have proliferated and elongated after 20 hours 
(scale bars = 200 μm). (e) 2D migration rate of BeWo as a function of EGF 
concentration. Migration rates were measured by tracking individual cells in 
microscopy video over 20 hours. Error bars indicated standard errors and * indicated 






















Figure 2.4: Transport of Phenomena of EGF in 3D Printed GelMA.  (a-d) Time 
lapse images Texas red-tagged EGF diffusing radially from the center of the 3D-
printed GelMA discs dosed at 0.7 μM (scale bars = 200 μm).  (e) Design of the 
diffusion study. Blue indicated GelMA region and red indicates GelMA loaded with 
EGF. Black box indicated where the time lapse images were taken. (f) Diffusive flux 
of EGF as a function of time obtained through integrating concentration profiles from 















Figure 2.5: Mathematical Model Results of EGF Diffusion in GelMA.  (a) 
Concentration profile of EGF as a function of radius and time with a perfect source of 
6 μM. (b) Concentration profile of EGF as a function of radius and time with a 
perfect source of 13 μM. (c) EGF concentration at radius of 5 mm, where the cells 





















Figure 2.6: Concentration Profiles of EGF and Glucose in BPM.  (a) Diffusion of 
EGF in GelMA over 8 days. The EGF was diffusing out from the center source (13 
µM) of the disc outwards radially towards the edge of the disc where the cells were 
located. The distance between the EGF source and the cell was 0.25 mm. The 
concentration of EGF at the edge of the disc (where the cells were located) reached 
target concentration (0.1 µM) at around 3 days. The concentration gradient between 
the EGF source and the cells remained over 8 days. Scale represented concentration 
of EGF in µM. (b) Diffusion of glucose in GelMA in 32 hours. In this model, glucose, 
which served as a model for the nutrients coming from the surrounding media, was 
diffusing from the edge to the center of the BPM. Our results demonstrated glucose 
concentration would be homogenous within the disc in 32 hours. Scale represented 
concentration of glucose in mM. (c) EGF concentration profile at 32 hours (d) 
Glucose concentration profile at 32 hours. At 32 hours, glucose reached equilibrium 
(glucose concentration gradient is less than 0.1%) while the concentration differences 






2.3.3 Bioprinting of the Simplified Bioengineered Placental Model (BPM) 
Based on the results above, we designed and bioprinted the BPM (Figure 
2.1).  We measured the distance between the edge of the BPM and the migration front 
of the trophoblast cells at regular intervals for 8 days (Figure 2.7a, red arrows).  We 
then used the average distance over time and successfully quantified migration rate 
(Figure 2.7b).  We demonstrated the migration of trophoblasts by comparing 
microscopy images between Day 2 and Day 8 (Figure 2.7a, left column, scale bar = 
200 μm).  Day 2 was selected as a reference time point to allow the printed hydrogel 
to reach equilibrium with the surrounding media before measuring migration.  As 
shown, there seems to be a dosage-dependent migratory response of trophoblasts 
towards EGF, where higher concentration of EGF results in larger trophoblastic 
migration rates which correlates well with our 2D results.  The average migration 
distance of BeWo cells towards 6 µM and 13µM over 8 days are 52 µm and 101 µm, 
respectively.  The EGF concentration depicted in the legend of Figure 2.7b indicates 
the loading level of EGF at the center of the BPM at t = 0 (red in Figure 2.1).  We 
have also confirmed excellent viability (>90 %) of printed BeWo cells via live/dead 
staining after 8 days of culture (Figure 2.7c, d).  To further demonstrate the validity 
of the BPM, we quantified migration of human mesenchymal stem cells (hMSCs), 
another cell population present in the decidua that has been demonstrated to promote 
trophoblast invasion[139, 140], using a similar approach (Figure 2.8).  Similar to 
trophoblastic migration, we observed a dosage-dependent response of hMSC 
migration towards EGF (Figure 2.8b), which agrees with previous literature [145].  





993 µm and 1146 µm respectively.  We have also confirmed excellent viability (>90 
%) of printed hMSCs via live/dead staining after 8 days of culture (Figure 2.8c, d).  
Herein we report the first 3D printed, in vitro bioengineered placenta model 
that can be used for to study preeclampsia.  We have demonstrated that the 
biophysical properties, the placement of the biomaterials, and the chemotactic 
gradients of BPM can be engineered to better mimic those of the native tissue, which 












Figure 2.7: Results from the Trophoblast Migration Model.  (a)  Overall model 
design and representative microscopy images at day 0 and day 8 showing trophoblast 
migration (Scale bars = 100 μm).  (b)  Migration rate of BeWo cells under different 
concentration of EGF, which demonstrated a dosage-dependent migratory response of 
trophoblasts towards EGF.  (c,d) Fluorescent live/dead stain images taken at Day 8 


















Figure 2.8:  Results from the hMSC Migration Model.  (a) Overall model design 
and representative microscopy images at day 0 and day 5 showing hMSC migration 
(scale bars = 200 μm).  (b) Migration rate of hMSCs under different concentration 
EGF, which demonstrated a dosage-dependent migratory response of hMSCs towards 
EGF.  (c,d) Fluorescent live/dead stain images taken at Day 8 indicating excellent 















Despite the efforts to better understand the pathogenesis of preeclampsia, no 
effective treatment is available today other than early delivery of the fetus and 
placenta prematurely due to the lack of effective in vitro models [9].  Current in vitro 
models that are used to study trophoblast invasions are 2D, which lack the complex 
elements of the decidua (maternal vasculature, heterogeneous cell populations, 
extracellular matrix, and biochemical signals) [11], which play essential roles in 
trophoblast migration. 
To this end, we developed a 3D printing platform that is able to fabricate 
tissue engineered constructs with biophysical properties that closely mimic those of 
the placenta.  We began by characterizing the stiffness of ex vivo term placenta using 
SWE.  Utilizing SWE, we could successfully distinguish between the maternal 
decidua and the fetal villi, and measured the Young’s modulus of maternal decidua 
where trophoblast migration occurs (11.84 ± 1.05 kPA, Figure 2.2i).  If we were to 
use DMA, we would have to manually separate the placenta into respective parts, 
which would be cumbersome and could introduce bias.  After obtaining the stiffness 
of regions of interest from characterizing ex vivo tissues, we then 3D printed 5% and 
10% GelMA constructs and measured the Young’s modulus through DMA, the 
current gold standard of evaluating mechanical properties.  The Young’s modulus in 
5% and 10% GelMA were found to be similar to that of maternal decidua (Figure 
2.2k).  The swelling ratio of both 5% and 10% GelMA were greater than 0.95, which 
indicates that they allow for diffusion of nutrients that is essential for cell 





tested the Young’s modulus of 3D printed GelMA constructs using both methods and 
found no significant differences between the values (Figure 2.2k).  Since it has been 
demonstrated in previous studies that cells elongated and migrated more in 5% 
GelMA hydrogels compared to those of GelMA hydrogels at higher polymer 
concentrations (10 and 15 % (w/v))[142], and that the stiffness of 5% GelMA is 
within the same order of magnitude as that of native tissue, we decided to move 
forward with 5% GelMA.  We expect the trophoblasts embedded in GelMA will 
remodel their ECM overtime to achieve physiological stiffness in our BPM.  In the 
future we plan on investigating the effect of matrix mechanics on trophoblast 
migration.  To confirm our printing platform can recapitulate the complex maternal 
vasculature, we have printed constructs which include an inner spiral geometry 
(Figure 2.2e-h).  We will evaluate the effect of vasculature geometry on trophoblast 
migration in later studies.    
After developing the biomaterial and printing platform that captures the 
biophysical properties of the maternal decidua, we aimed to 3D print a bioengineered 
placenta model with appropriate cells, ECM, and growth factors based on bioprinting 
technologies to assess cell migration (Figure 2.1).  The BPM is based on a cylindrical 
gelatin methacrylate hydrogel, a highly biocompatible and biodegradable biomaterial 
[129-132, 146], loaded with varying components at different radial positions.  To 
decide on the dosage of EGF, we measured the migration rate of BeWo cells on 2D 
fibronectin-coated glass through time-lapse microscopy (Figure 2.3).  The results 
demonstrated a dosage-dependent response where higher EGF concentration leads to 





identified the physiologically relevant concentration range of EGF to that can induce 
trophoblast migration, and we would like to replicate the concentration in the BPM.  
To accomplish this, we characterized the transport phenomena of EGF through 
GelMA (Figure 2.4a) through time-lapse images of fluorescently-tagged EGF.  By 
using a standard diffusion equation, we used MATLAB to calculate a diffusion 
coefficient of EGF in GelMA to be 2.5 × 10-8 cm2/s, which resulted from the least 
mean squared error between the experimental and model results.  The diffusion 
coefficient is lower than the effective diffusion coefficient of EGF through murine 
soft tissue[147].  We believe this is mainly due to the electrostatic interactions 
between GelMA and EGF, as type A gelatin and EGF carry opposite charges in 
physiological conditions[133, 147].  We then used the optimized diffusion coefficient 
to model the concentration profile for 8 days (Figure 2.5, 2.6).  We then decided on 
the loading level of 6 and 13 μM that results in physiological relevant level of EGF at 
the location of the cells by day 3 (Figure 2.5).  We believe these loading levels will 
result in an EGF concentration profile to induce trophoblast migration within 8 days.  
To investigate the diffusive fluxes of nutrients and EGF within BPM, we evaluated 
and compared the magnitudes between the two opposing gradients caused by the 1) 
nutrients diffusing from the edge towards the center of BPM and 2) EGF diffusing 
from the center of the towards the edge of the BPM.  Using glucose as a model, our 
results showed that the concentration of nutrients will be homogenous throughout the 
construct in just 32 hours, whereas the determined concentration gradient at that time 
is at least an order of magnitude different (Figure 2.6c, d). We are confident that the 





because 1) small molecules such as glucose or fructose will be homogeneously 
distributed in BPM within 1.5 days (Figure 2.6b) and 2) concentration of larger 
molecules such as proteins and growth factors in the surrounding media is six orders 
of magnitude lower than our printed EGF source [48, 148-152] (pico- vs micro-, 
respectively). Overall the evolution of concentration gradients and the development 
of a diffusion model demonstrate that concentration of biomolecular species changed 
with time in a predictable manner which can be controlled and engineered to develop 
3D migration models. 
Once we identified the parameters needed to bioprint the BPM, we tested the 
validity of the BPM by confirming the chemotactic effect of EGF on trophoblasts and 
hMSCs quantitatively (Figures 2.7, 8) [141] .  Our results indicated a dosage-
dependent migratory response of trophoblasts towards EGF in a 3D matrix.  These 
results demonstrate that EGF is a potential therapeutic agent for preeclampsia by 
directly promoting trophoblast invasion, which agrees with other published work 
[29].  To further validate the BPM, we tested migration of hMSCs, another cell 
population that is present in the placenta, towards EGF.  Our results indicated a 
dosage-dependent migratory response of hMSCs towards EGF in a 3D matrix.  This 
result suggests that EGF can indirectly treat PE by recruiting hMSCs from the 
maternal side to the site of trophoblast invasion, as hMSCs have been shown to 
alleviate symptoms of PE in vivo [139] and to have enhanced the migration and 
invasion abilities of trophoblast cells in vitro [140]. 
To the best of our knowledge, the BPM developed herein is the first 3D in 





chemokines to induce trophoblast and hMSC migration.  Such unique and clinically 
critical biophysical information as tissue elasticity and chemotactic gradient has not 
been previously incorporated to build a functional tissue model for study of disease 
and treatment development.  Even though our BPM is a simplified model of the 
trophoblastic invasion, the methodology of utilizing SWE, diffusion modeling, and 
finally 3D printing to build a tissue model to study trophoblast migration will serve as 
a platform for developing more complex, physiological placental models in future 
studies. The current BPM allows the researcher to evaluate bulk population migration 
and in the future, we would like to improve the placenta model to track single cell 
migration including rate and direction.  We believe our bioengineered placenta model 
will serve as a platform that will continue to shed light on placental biology and allow 
researchers to develop novel treatments for preeclampsia.  Unlike current in vitro 
models, such as transwell permeable supports, the BPM can allow for the 
quantification of migration rates of different placental cell populations through 3D 
extracellular matrix, which is a significantly more realistic representation of the in 
vivo environment compared to current 2D models.  While this work centers itself in 
the theme of placental tissue engineering to study preeclampsia, we foresee utilization 
of our tissue modeling approach to study cell migration in other contexts such as 
migration of fibroblasts in wound healing and/or stem cell homing to site of injuries.   
2.5 Conclusion 
In this work we have successfully developed the first 3D printed, 
bioengineered placenta model to study and quantify trophoblast and hMSC migration.  





tissue, have modeled the diffusion of chemokines as well as nutrients, and finally 
have used bioprinting technology to fabricate a placenta model with spatial control of 
cells, growth factors, and ECM.  To demonstrate the efficacy of our bioengineered 
placenta model, we evaluated the effect of EGF on 3D trophoblast migration and 
found a positive relationship between EGF dosage and trophoblast and hMSC 
migration rates. These results suggest that the EGF can directly treat PE by promoting 
trophoblast migration and indirectly treat PE by recruiting hMSCs from the maternal 
decidua.  This work is a first step towards building a more sophisticated 
bioengineered placenta model that will be a powerful tool for researchers to test and 
to develop novel treatments for preeclampsia.  We envision that our tissue modeling 
approach presented in this work will not only be used to explore trophoblastic 
migration in the context of preeclampsia, but also in other processes such as 
migration of fibroblasts in wound healing and/or stem cell homing to the site of 






Chapter 3: Placental Basement Membrane Proteins are Required 
for Effective Trophoblast Invasion 
3.1 Introduction 
In normal pregnancy, embryo implantation and placentation occur by 
trophoblast invasion of the maternal spiral arteries to create a low-resistance, high-
flow maternal uteroplacental circulation [6, 9, 121, 122]. Impaired trophoblast 
invasion of the maternal spiral arteries results in abnormal placentation leading to 
reduced placental perfusion and oxidative stress [6, 9, 52, 121, 122].  One of the 
major clinical complications of impaired trophoblast invasion is preeclampsia (PE) 
[16].  PE is a leading cause of maternal and perinatal morbidity and mortality 
affecting 3 to 8% of all pregnancies [6, 9, 107, 121, 124] and resulting in 29,000 
deaths yearly in US [153].  The only treatment option for PE available is the 
premature delivery of baby and placenta because the mechanisms of trophoblast 
invasion are poorly defined [6, 9, 11].  
In early placental development, trophoblasts differentiate and lose their 
organized epithelial phenotype and transitioning to a more migratory and invasive 
mesenchymal phenotype which allows them to infiltrate the maternal decidua and 
spiral arteries. This transition has been recently suggested as a type of epithelial-
mesenchymal transition (EMT) that involves upregulating and secreting matrix 
metalloproteinase (MMP) and gaining the ability to migrate and invade [31-34, 37]. 
EMT has been reported to be mediated by tyrosine kinase receptors (TKR) and TGF-





impact on endometrial susceptibility to implantation in vivo based on a murine TKR-
ablated uterus model (EGFR knock-out) [51]. Moreover, EMT is mediated through 
the action of PI3K signaling pathway [33, 35], a major signaling pathway located 
downstream of TKR that regulates cellular processes including motility, proliferation, 
survival and growth– which are critical for trophoblast invasion [52, 55, 60]. 
However, the effect of extracellular matrix (ECM) microenvironment on EMT and 
PI3K signaling on trophoblast invasion remains poorly understood.  
Cell-ECM interactions play a fundamental role in the growth, differentiation 
and invasion of trophoblasts [120]. Prior to implantation of blastocysts, the maternal 
endometrium undergoes substantial remodeling and differentiation to become 
decidua, a process known as decidualization [51, 154].  When decidualization occurs, 
the maternal decidual stromal cells (those in direct contact with trophoblasts) produce 
pericellular basement membrane (BM) proteins that are critical to placental 
development and successful embryogenesis. For example, knocking out laminin 
genes in murine models cause embryonic lethal outcomes (Lama1; Lama5; Lamb1; 
Lamc1) and considerable abnormalities in vascular and trophoblast differentiation 
during placental development (Lama5) [155, 156]. These placental abnormalities are 
potentially caused by the lack of stable adhesion between trophoblasts and Lama5-
deficient murine. Moreover, human term placenta from preeclamptic pregnancies 
have lower expression levels of laminin compare to those of normal pregnancies 
[157-159]. The expressions of laminin alpha 2 appears to also be downregulated in 
the basal plate of preeclamptic term placenta [160]. Even though these evidences 





majority of published literature focuses on the effect of soluble factors [120]. The 
intricate and highly ordered nature of ECM makes it difficult to reproduce using 
synthetic or purified components and these BM-proteins are often tissue-specific and 
work in concert instead of individually [120, 156, 161].  These differences in ECM 
compositions between native tissue and in vitro culture techniques affect cellular 
genotypes and phenotypes [120]. Therefore, studies on cell invasion utilizing single 
ECM components, while still valuable, may not represent the in vivo environment.  
Our hypothesis is that placental BM proteins from basal plate of human 
placenta (pECM) are required for effective trophoblast invasion. To test this 
hypothesis, we isolated and characterized pECM from the basal plate of term human 
placenta. Through proteomics, we determined that more than 80% of pECM consists 
of BM proteins. Our results show that the addition of isolated placental BM proteins 
in pECM substantially increased the invasion rates by 13-fold while significantly 
upregulated the gene expressions of MMP2 and MMP9 (surrogate markers for 
invasion and EMT [55, 162]). The addition of LY294002, a well-established PI3K 
inhibitor [52, 60], significantly reduced the enhanced invasive rates and expressions 
of MMP2 and MMP9. These results demonstrated that the placental BM proteins 
stimulated trophoblast invasion predominantly through PI3K signaling - first direct 
evidence indicating that the trophoblast differentiation and invasion are critically 







3.2 Materials and Methods 
Cell Culture 
BeWo cells were purchased from ATCC and cultured in Dulbecco’s Modified 
Eagle’s Medium (DMEM, ATCC), 15% (vol/vol) Fetal Bovine Serum (FBS; Thermo 
Fisher Scientific), and 1% penicillin/streptomycin (Pen/Strep; Thermo Fisher 
Scientific).  
 
Tissue Collection and Isolation 
Ex vivo placentae were collected from MedStar Washington Hospital Center 
according to protocol approved by the MedStar Research Institute Institutional 
Review Board (IRB# 2015-131). The placentas are frozen at -80 immediately after 
delivery until tissue isolation. Surgical tools (e.g. scissors, scalpels, forceps) were 
utilized to carefully harvest the top slice of the placenta from the maternal side (no 
more than 3 mm). The isolated tissue is then minced and washed using until the 
effluent become clear.  
 
Decellularization and Digestion of Basal Plate 
The decellularization and digestion protocols are developed based on previous 
studies[161, 163].The minced tissues are treated with 1% (v/v) antibiotic/antifungal 
(Thermo Fisher Scientific) and place on a shaker overnight at room temperature. The 
tissue is then treated in 0.1% Sodium Dodecyl Sulfate (SDS) in dH2O for 48 hours to 
decellularize the tissue. Following SDS treatment, the tissue is washed in distilled 





crushed using a mortar and pestle set and digested in pepsin (1g of pepsin / 10 g of 
dry tissue) in 0.5M acetic acid in 4 oC for 48 hours. The pH of the tissue digest is 
adjusted to 7.4 using an aqueous base solution (e.g. NaOH) and then centrifuged at 
3000 g for 5 mins. The supernatant is filtered using a cell strainer (100 µm) and 
stored at -80 until further use.  
 
Gelatin Methacrylate Synthesis 
Gelatin methacrylate was synthesized according to previously published 
methods[129-131].  Briefly, Type A porcine skin gelatin (Sigma-Aldrich; 300 bloom) 
was mixed at 10% (w/v) in phosphate buffered saline (PBS; Thermo Fisher 
Scientific) at 50 oC for 20 minutes. Methacrylic anhydride (MA, Sigma-Aldrich) was 
then added at 0.6 g of MA / g gelatin under rigorous stirring for an hour. The 
reactants were then diluted 2x with PBS to stop the reaction. The mixture was 
centrifuged, and the pellet was discarded. The supernatant was dialyzed against 
deionized water at 50°C using dialysis cassettes (10kDa MWCO, Thermo Fisher 
Scientific) for at least 3 days. The deionized water was changed twice a day to 
remove salts and excess methacrylic acid. The dialyzed GelMA was then lyophilized 
for at least 3 days and store at -80°C until further use. 
 
Proteomics 
The digested ECM sample was dissolved in SDS-loading buffer and separated 
by size using a 10% acrylamide gel by SDS-PAGE. The gel was then fixed and cut 





digested with sequencing grade Trypsin (Promega) and the resulting peptides were 
extracted with acetonitrile-formic acid buffer.  The peptide mixtures from each band 
were sequentially analyzed by liquid chromatography-mass spectrometry (LC-MS) 
using nano-LC system (Easy nLC 1000, Thermo Fisher Scientific) connected to Q 
Exactive mass spectrometer (Thermo Fisher Scientific). The peptides were eluted at a 
flow rate of 300 nL/min using linear gradients of 2-25 % Acetonitrile for 35 min, 
followed by 25-40% for 10 min, 40-60% for 1 min, and static flow at 60% for 14 min. 
The MS raw data were searched against UniProt database that also included common 
contaminants using MaxQuant software (version 1.5.5.1). 
 
Size Exclusion Chromatography (SEC) 
250µL of digested placenta sample (prepared as specified above) were loaded 
onto a ENrichTM SEC 650 column (Bio-Rad) using the NGC QuestTM 10 
chromatography system (Bio-Rad) which was equilibrated with 1x PBS. Proteins 
were eluted from the column using 1x PBS as mobile phase at a flow of 1mL min-1 
while monitoring the absorbance at 280nm. Samples were collected in 0.7mL 
fractions using a fraction collector (BioFracTM, Bio-Rad) and frozen at -20°C until 
further use. 
 
Cell Adhesion Study 
Adhesion of trophoblasts to pECM was evaluated using the washing assay.  
This assay relies on seeding cells onto substrates of interest and washing off 





cells[1-3, 164].  Briefly, a 24 well plate (not tissue culture treated, Corning) was first 
treated with FBS for 2 hours and then coated with desired ECM overnight, both at 
4oC. Trophoblasts were stained with Calcein AM (Thermo Fisher Scientific) 
following manufacturer’s recommendations and seeded on the treated cell culture 
wells in culture media. The cells were allowed to adhere for 2 hours at 37 oC and then 
an initial fluorescent readings (F1) was taken using a fluorescent plate reader. Then 
the wells were washed twice with PBS to remove non-adherent cells and the 
fluorescence was read again (F2).  Fraction of adhesion (FA) was calculated using the 
formula: FA= 1 - (F1-F2)/F1. 
 
Bioprinting of Placenta Model with pECM 
All bioprinting work was completed using a commercial bioprinter (3D-
Bioplotter; EnvisionTEC).  To prepare the prepolymer solution, lyophilized GelMA 
was dissolved in complete growth media at 50°C for 20 minutes. Photoinitiator (2-
hydroxy-1-(4-(hydroxyethoxy)phenyl)-2-methyl-1-propanone; Irgacure 2959; BASF) 
was then added into the GelMA solution at 0.1% (w/v) at 50°C for 15 minutes. The 
prepolymer solution was loaded into the low-temperature printer head and allowed to 
equilibrate for 30 minutes at 37°C. Additional biomaterials such as pECM, cells, 
and/or growth factors of interest were added at this point, and the functionalized 
prepolymer solution was loaded into printing cartridge and allowed to equilibrate to 
printing temperature (e.g. ~23°C) for another 30 minutes prior to printing. Printed 
constructs were UV-cured for 30 seconds (0.09 mW/cm2) using a UV box (VWR). A 









For the invasion experiments, cells were bioprinted (2 million cells/mL) along 
the periphery of the cylindrical placenta model with a chemotactic source (epidermal 
growth factor, 10 µM) at the center as previously described[5].  Cells were cultured in 
growth media with low serum concentration (5%) and phase-contrast images were 
taken on day 2 and day 7. The distance between the edge of the placenta model and 
the invasion fronts were measured and averaged over time to obtain invasion rates.  
For samples with reduced PI3K signaling, samples were treated with LY294002 (25 
µM) on days 4 and 6 for 24 hours. 
 
DNA Isolation and Quantification 
Sample discs (10 mm diameter and 2 mm height, 2 million cells/mL) were bioprinted 
for gene expression studies. On day 7, bioprinted discs were treated with papain (4 mg/mL) 
for 20 mins at 37°C to dissolve the gel. Cells were lysed with RIPA Lysis and Extraction 
Buffer (Thermo Fisher Scientific).  A Quant-iT PicoGreen dsDNA Assay kit (Life 
Technologies) was used to quantify DNA following the manufacturer’s protocol.   
 
RNA Isolation and qRT-PCR 
Sample discs (10 mm diameter and 2 mm height, 2 million cells/mL) were bioprinted 
for gene expression studies. On day 7, bioprinted discs were dissolved by treating them with 





the trophoblasts using the RNeasy Plus Mini Kit (Qiagen) and then reverse transcribed to 
complementary DNA (cDNA) using a High Capacity cDNA Archive Kit (Thermo Fisher 
Scientific).  Quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) was 
performed by combining the cDNA solution with a Universal Master Mix (Thermo Fisher 
Scientific), as well as oligonucleotide primers and Taqman probes for MMP2, MMP9 and the 
endogenous gene control glyceraldehyde-3-phosphate dehydrogenase (GAPDH; Life 
Technologies).  The reaction was performed using a 7900HT real-time PCR System (Applied 
Biosystems) at thermal conditions of 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 
95°C, and 1 min at 60°C. The relative gene expression level of each target gene was 
normalized to the mean of GAPDH in each group then the fold change was determined 
relative to the Bioprinted Placenta Model without pECM.  Fold change was calculated using 
the ΔΔCT relative comparative method as described previously[116].   
 
Measurement of MMP Activity 
Supernatant of bioprinted placenta model with different dosage of pECM were 
collected after 7 days of culture. The MMP activity was measured using the MMP Activity 
Assay Kit (Abcam) according to manufacturer’s instructions.  
 
Statistical Analysis 
Error bars indicate standard deviation and * indicates statistically significant 
differences between groups. Data from all the studies were analyzed using the 
Multiple Comparison Test function in MATLAB. A confidence level of 95% was 
chosen, and p-values below 0.05 were considered significant. All experiments were 






3.3.1 Isolation and Characterization of Placental Basement Membrane Proteins (pECM) 
To harvest relevant extracellular matrix (ECM) material to study trophoblast 
invasion, we isolated the basal plate of the fresh human term placentae by removing a 
thin layer (less than 3 mm) of tissue from the maternal side (Figure 3.1a, red arrows). 
Following decellularization and solubilization, the amount of DNA present in it the 
processed tissue was 95% lower than that of solubilized native tissue (Figure 3.1d) 
and was below the level indicated to induce immune response[165]. The 
decellularized and solubilized ECM isolated from term placenta is referred to as 
pECM for the rest of the work (Figure 3.1b,c). Next, we compared the amounts of 
collagen in pECM to solubilized native tissue and showed no significant differences 
(Figure 3.1e). These data show that the decellularization treatment was effective in 
removing the DNA contents and kept the ECM components intact which was 
demonstrated by the similar collagen levels. Since the mechanical properties of the 
substrate have a profound impact on cellular behavior[166], we used compression test 
and determined that the pECM has no significant impact (p>0.05) on the Young’s 
modulus and yield strength of bioprinted GelMA constructs (Figure 3.1f). Therefore, 
any biological effects induced by pECM on trophoblasts were due to differences in 









Figure 3.1. Development of Decellularized Placental ECM (pECM). (a) Anatomy 
of ex vivo placenta. Top image illustrated the major structures of human placenta and 
bottom image demonstrated a cross section of human placenta sample. Red arrows 
indicated the location of basal plate. (scale bar = 10 mm). (b) Representative image of 
lyophilized pECM. The tissue of basal plate was lyophilized for long term storage 
after it has been decellularized. The lyophilized pECM was a porous scaffold with 
white-yellow appearance. (c) Representative image of solubilized pECM. The 
lyophilized pECM was solubilized in pepsin under acidic condition at a desired 
concentration (0.1% w/v) to be bioprinted later. (d) DNA content of solubilized 
ECM. After treatments of SDS and DNase (blue), 95% of the DNA from the native 
tissue was removed (red) (n = 3). (e) Collagen content of solubilized ECM. There was 
no significant difference between the collagen contents of solubilized decellularized 
and native tissue, which suggested the integrity of the ECM was well-preserved after 
decellularization treatment (n = 3). (f) Effect of pECM on the mechanical properties 
of bioprinted constructs. Our results showed that the addition of pECM into 
bioprinted GelMA constructs did not alter the Young’s modulus and yield strength 
significantly (n = 6). Error bars indicated standard deviation and * indicated 






3.3.2 Effect of pECM on Proliferation and Adhesion of Trophoblast 
Since trophoblasts are anchorage-dependent and their binding to ECM is 
required to invade the decidual matrix, we tested the effect of pECM on proliferation 
and adhesion of trophoblast. As shown in Figure 3.2a, the fraction of adhered cells 
for pECM-coated group (0.82±0.05) was significantly higher than those of untreated 
plastic (0.35±0.19) and GelMA coated plastic (0.38±0.24). GelMA was used as a 
control because it is the basis material for our bioprinting work. In addition, the 
fraction of adhered cells on pECM coated wells was comparable to that of the 
fibronectin coated wells (0.85±0.06), a widely-used ECM matrix that promotes cell 
adhesion[5, 154]. In addition, we observed that the addition of pECM enhances the 
proliferation of bioprinted trophoblasts in a dosage-dependent manner (Figure 3.2b). 
Qualitative images using live/dead viability staining kit demonstrated that the 
additional pECM did not affect the viability of bioprinted trophoblasts with mostly 
viable cells (green) and very few dead cells (red, Figure 3.2c). Encapsulated 
trophoblasts form a sub-population of aggregates and appeared differently than 2D 
culture in bioprinted GelMA constructs, consistent with published literature with cells 
encapsulated in hydrogels (Figure 3.2d) [63]. These results demonstrated that pECM 









Figure 3.2. Effect of pECM on Growth of Trophoblasts. (a) Effect of pECM on 
relative adhesion. A washing adhesion assay, which was qualitative, was performed 
to test the relative adhesion of trophoblasts on different substrate coating [1-4]. Our 
results showed that pECM coating significantly increased the adhesion of 
trophoblasts compared to non-tissue culture treated polystyrene and GelMA coating. 
In addition, the fraction of adhesion was not significantly different from fibronectin, 
the most extensively utilized ECM to promote cell adhesion in biomedical research. 
(b) Effect of pECM on proliferation of trophoblasts. The mass of DNA of bioprinted 
trophoblasts encapsulated in different concentrations of pECM were quantified after 7 
days of culture (normalized to day 0). Our results demonstrated a dosage-dependent 
response of DNA mass and concentration. (c) Representative live/dead images of 
bioprinted trophoblasts. The cells were stained with calcein-AM (green) for live cells 
and propidium iodide (red) for dead cells. The majority of the bioprinted trophoblasts 
were stained live (green) with very little dead (red) (scale bar = 100 µm). (d) 
Representative live/dead images of trophoblasts demonstrating formation of 
aggregates. The cells were stained with calcein-AM (green) for live cells and 
propidium iodide (red) for dead cells. (scale bar = 100µm). Error bars indicated 






3.3.3 Characterization of Complete and Fractionated pECM 
Since pECM is a mixture of ECM proteins, we used proteomics to determine 
its composition to elucidate the mechanism behind the interactions between pECM 
and trophoblast. Using proteomics, we found the pECM was composed of mostly BM 
proteins (80% by peptide counts), including laminin, collagen, fibronectin, Howe 
sulfate proteoglycan (Figure 3.3a), and these results were validated by Western blot 
analyses (Figure 3.3b). To evaluate if the effect of pECM was due to the placental 
BM proteins, we used size-exclusion based chromatography (SEC) to separate pECM 
components into high molecular weight (>158 kDa, referred to as HMW-pECM) and 
low molecular weight (<3.5 kDa, referred to as LMW-pECM) as indicated by the two 
peaks in Figure 3.3c. Relative amount of ECM proteins in these two fractions were 
determined using proteomics (Figure 3.3a). Our results indicate that key placental 
BM proteins such as laminin, collagen, fibronectin, heparan sulfate proteoglycan, and 
nidogen were depleted in LMW-pECM as their amounts are lower than that of 
















Figure 3.3 Characterization of Fractionated and Complete pECM. (a) 
Compositions of fractionated and complete pECM. We found that there was ample 
basement membrane (BM) proteins including laminin, collagen (VI, VI, XII, XIV and 
XV), fibronectin, BM-specific heparan sulfate proteoglycan in pECM which consist 
of more than 80% peptide fractions. Moreover, we quantified the peptides of ECM 
molecules and calculated the ratio of HMW over LMW pECM. We found that the 
amounts of placental BM proteins were at least two orders of magnitude higher in 
HMW pECM than that of LMW pECM. (b) Western blot results. SDS-page and 
positive immunostaining of collagen I, II served as confirmation of the proteomics 
results. (c) Chromatogram of solubilized pECM after eluting through a SEC column. 
Samples were taken from the high molecular weight fractions (defined as HMW 
pECM, MW>158 kDa) and low molecular weight fractions (defined as LMW pECM, 








3.3.4 Effects of Fractionated pECM on Trophoblast Invasion  
Once the compositions of the fractionated and complete pECM were 
determined, we tested their effects on trophoblast invasion rates of BeWo cells, an 
epithelial trophoblastic cell line that is extensively used to study placental 
development[11, 29], in a bioprinted placenta model (BPM)[5]. BeWo cells was used 
instead of HTR8 because we wanted to study epithelial-mesenchymal transition of 
trophoblasts and HTR8 is considered mesenchymal-like based their positive 
expression for vimentin[167]. The concentrations of ECM protein were kept constant 
at a level that was comparable to current in vitro studies[5] across all groups in 
Figure 3.4c. The trophoblast bioprinted in LMW-pECM had a lower invasion rate 
compared to those of HMW-pECM (17.6±8.19 versus 36.1±12.5 µm/day, 
respectively; Figure 3.4c). Interestingly, however, both invasion rates were lower 
than that of complete pECM (65.8±37.5 µm/day; Figure 3.4c). These results 
indicated the effect of complete pECM on trophoblast invasion cannot be reproduced 
using individual fractions alone, suggesting a combination mechanism of action of 
both placental BM-proteins and peptide components. To confirm that invasion 
required the expression of MMP, a known group of enzymes that are responsible for 
the degradation of ECM proteins and are upregulated during EMT and invasion of 
trophoblasts[36, 162], we tested the effect of fractionated and complete pECM on the 
gene expressions of MMP2 and MMP9 (Figure 3.5) [60, 168]. HMW-pECM 
upregulated the expressions of MMP2 and MMP9 significantly (p<0.05) compared to 
LMW-pECM and the control group (Figure 3.5a,b). LMW-pECM, on the other hand, 





though HMW-pECM upregulated MMP2 and MMP9 expressions, the magnitudes 
remained lower than that of complete pECM (1.40 versus 1.55 and 2.39 versus 5.99-
fold change, respectively), again suggesting there may be synergistic effects between 

















Figure 3.4. Effect of pECM on Trophoblast Invasion. (a) Overview of bioprinted 
placenta model. The bioprinted placenta model was based on previously published 
work that has a layer of trophoblasts along the periphery of a cylindrical disc (green) 
with a chemoattractant at the center. Placental BM proteins were incorporated with 
GelMA throughout the placenta model. (b) Representative images of trophoblast 
invasion. By taking images of trophoblasts at day 2 (red) and day 7 (green), we 
observed the shift in the invasion fronts. We calculated the invasion rates by taking 
the differences between the invasion fronts and average over time. (c) Effect of 
fractionated pECM on invasion rates of trophoblasts. The trophoblasts bioprinted in 
complete pECM had the highest invasion rates (n = 3), followed by HMW-pECM (n 
= 3) and then LMW-pECM (n = 3). (d) Trophoblast invasion rates as a function of 
pECM and PI3K inhibitor. The pECM at both dosages (0.02 and 0.2 mg pECM/mL, n 
= 3) significantly increased invasion rates of trophoblasts compared to the control 
BPM without any pECM (n = 3). The addition of LY29002, a PI3K inhibitor, 
significantly reduced the effect of pECM on the invasion rates when compared to 
their respective dosage of pECM (n = 3). Moreover, there’s no statistically significant 
differences between the invasion rates of control BPM with no pECM and groups 
treated with PI3K inhibitor (n = 3), which indicated that the effect of pECM was 
completely removed. (e) Effect of pECM and PI3K inhibitor on MMP activities. A 
similar pattern was observed in the amount of MMP activity where pECM increased 
MMP activities significantly at both dosages (0.2 and 0.02 mg pECM/mL, n = 3) and 
the addition of PI3K inhibitor significantly reduced the effect of pECM (n = 3). Error 
bars indicated standard deviation and * indicated statistically significant differences 





3.3.5 Mechanism of pECM-induced Trophoblast Invasion  
Finally, we determined trophoblast invasion rates as a function of pECM 
concentrations to test our hypothesis that placental BM-proteins are required for 
effective trophoblast invasion. Our results showed that pECM, at both dosages (0.02 
and 0.2 mg pECM/mL), significantly increased invasion rates of trophoblasts 
(65.8±37.5, and 75.5±21.8 µm/day, respectively; p<0.05; Figure 3.4d) compared to 
control BPM with no pECM (5.6±1.0 µm/day). Similarly, the addition of pECM 
increased MMP activities but only significantly at a higher pECM concentration (0.2 
mg pECM/mL; p<0.05; Figure 3.4e). Since PI3K signaling is upstream of secretion 
of MMP and has been previously implicated in embryonic implantation, we tested its 
role trophoblast invasion[51, 60, 169]. The addition of a PI3K inhibitor (LY294002; 
25 µM) in the presence of pECM significantly reduced the invasion rates (12.6±10.4 
and 15.0±6.90 µm/day; p<0.05) compared to their respective dosages of pECM 
(65.8±37.5 and 75.5±21.8, respectively). Moreover, there were no statistically 
significant differences (p>0.05) between the invasion rates of control BPM and 
pECM groups treated with PI3K inhibitor, indicating that inhibiting PI3K signaling 
completely removed the effects of pECM. A similar pattern was observed in the 
amount of MMP activities (normalized to media) where pECM increased MMP 
activities (1.28±0.049 and 1.41±0.10; figure 3.4e) and the addition of PI3K inhibitor 
significantly reduced them (0.78±0.17 and 0.89±.27, respectively; p<0.05).  
At the genetic level, the addition of complete pECM (0.2 and 0.02 mg 
pECM/mL) significantly upregulated MMP2 gene expression (1.55±0.04 and 





(1.15±0.02 and 1.05±0.02, respectively; Figure 3.5a; p<0.05). Similarly, the addition 
of pECM significantly upregulated MMP9 (6.48±2.1 and 5.99±1.96, respectively; 
p<0.05) and were equally reduced when the PI3K was inhibited (1.24±1.1 and 
1.48±0.50, respectively; p<0.05; Figure 3.5b). Additionally, there were no 
statistically significant differences (p<0.05) between control BPM without pECM and 
PI3K inhibited groups in terms of MMP2 and MMP9 expressions, indicating that the 
effect of pECM on the gene expressions was completely removed by PI3K inhibitors. 
These results indicated that the pECM-enhanced invasion rates were correlated 
directly with upregulated of MMP2 and MMP9, and PI3K signaling appear to play a 























Figure 3.5. Mechanisms of pECM-enhanced Trophoblast Invasion. (a) Effect of 
pECM on the expressions of MMP2 of trophoblasts. The HMW-pECM increased the 
expressions of MMP2 significantly compared to LMW-pECM and control with no 
pECM (n = 3). The MMP2 expressions for HMW-pECM was lower than that of 
complete pECM with no significant differences (n = 3). LMW-pECM did not have a 
significant impact on the MMP2 expression (n = 3). The addition of pECM 
significantly increased the MMP2 gene expression compared to control (n = 3). 
However, the effect of pECM was completely removed when PI3K was inhibited 
with no significant differences with the control (n = 3). (b) Effect of pECM on the 
Expressions of MMP9 of Trophoblasts. The HMW-pECM increased the expressions 
of MMP9 significantly compared to LMW-pECM. However, the magnitude of 
HMW-pECM’s impact on MMP9 was substantially lower than complete pECM. On 
the other hand, LMW-pECM did not change MMP9 expressions significantly 
compared to control (n = 3). Moreover, the treatment of pECM increased the MMP9 
gene expression compared to control (0 mg pECM/mL) but again the effect was 
completely removed when PI3K inhibitor added with no significant differences with 
the control (n = 3). Error bars indicated standard deviation and * indicated statistically 







Trophoblast-ECM interactions play a fundamental role in placentation and are 
critical to placentation and pregnancy success [120]. However, there are very limited 
studies, if any, that examine the effect of ECM microenvironment on trophoblast 
invasion and differentiation. In this research, for the first time, the necessary and 
critical roles of placental BM proteins on trophoblast invasion were demonstrated. 
The addition of isolated placental BM proteins in pECM significantly increased the 
invasion rates by 13-fold and upregulated the gene expressions of MMP2 (1.5 fold) 
and MMP9 (6.3 fold) of trophoblasts. These pECM-enhanced invasive responses 
were completely removed upon the addition of PI3K inhibitor, suggesting placental 
BM protein stimulated trophoblast invasion predominantly through PI3K signaling.  
In preparation for embryonic implantation, the maternal endometrium 
undergoes substantial remodeling and differentiation to become decidua [51, 154] and 
causes the maternal decidual stromal cells (those in direct contact with trophoblasts) 
produce pericellular basement membrane (BM) [159]. Published studies have 
established the significance of BM proteins in placentation and embryogenesis in 
murine BM-proteins ablated models [156], human placental tissue [8, 158, 170], and 
trophoblast invasion in vitro [158, 171, 172]. However, none of the studies to date 
have directly determined the impact of extracellular placental BM proteins on 
trophoblast invasion. We found the placental BM proteins significantly increased 
trophoblast invasion rates and MMP expressions. If we used the invasion rates 
obtained through the placenta model loaded with pECM and assumed a decidual 





in 7 weeks, consistent with in vivo results from human pregnancies [173]. Without the 
presence of placental PM proteins, the trophoblast invasion was critically impaired, a 
condition that is associated with preeclampsia [6, 9, 52, 121, 122]. These findings, for 
the first time, exemplifies the necessary and critical role of placental BM proteins in 
normal trophoblast invasion. Since placental BM proteins are secreted from 
decidualization, our findings validate the importance of endometrial remodeling prior 
to the arrival of blastocyst. Future studies will involve incorporating decidual stromal 
cells into our tissue-specific placental model to assess their roles in trophoblast 
invasion. 
Our results showed that the placental BM proteins promoted trophoblast 
invasion predominantly through PI3K signaling, a critical signaling pathway 
downstream of RTK that regulates cell motility, proliferation, survival and growth 
[35, 60]. We demonstrated that the improved invasive phenotypes and genotypes of 
trophoblasts in the presence of pECM were completely removed when PI3K signaling 
was inhibited. This result was not surprising because other study demonstrated 
laminin binding activates the PI3K/AKT pathway in mammalian cells [174]. 
However, our results suggest that the reason for the failed implantation in RTK-
ablated uterus in a murine model [51] may be due to impaired trophoblast invasion 
and differentiation. Since PI3K signaling appeared to be an important signaling 
pathway that regulates the interactions between trophoblast and placental BM 
proteins, it could be an attractive potential therapeutic target for preeclampsia. 
However, further testing for other molecular pathways and inhibitors are necessary 





The ECM microenvironment plays a fundamental role in the maintenance of 
cellular phenotypes such as invasion [120, 161, 175]. There is strong evidence 
supporting that the interaction between ECM microenvironment and cells is mediated 
through receptor-ligand interactions and biomechanical stimuli, which in turn control 
cellular function [161, 175]. Recent studies have validated tissue-specific ECM 
improves cell function and intricate tissue formation [161, 176]. These ECM 
scaffolds were shown to have the capacity to direct tissue-specific cell lineage 
commitment and maintaining the phenotype of mature cell populations [161]. The 
cell-ECM interactions are extremely complex in nature and justify the need for a 
tissue-specific approach to recreate the native trophoblast niche to encourage and 
maintain their invasive phenotypes [161, 177]. As such, we isolated placental BM 
proteins from the basal plate of fresh term placenta because it is a rich source of 
invasive extravillous trophoblasts [177]. The primary amine groups of pECM should 
crosslink with the methacrylate side groups in GelMA through radical reactions 
[178]. It is unlikely that all pECM would be crosslinked with GelMA and their effects 
on trophoblast invasion is yet to be determined, although these soluble pECM could 
removed from the regular media changes. We found that we could not reproduce the 
biological effects of pECM using its fractionated components alone (pECM vs. 
LMW-pECM vs. HMW-pECM), which indicated that all components of pECM were 
required. Therefore, current literature on trophoblast biology that utilizes soluble, 
single ECM components and/or tissue culture polystyrene, while still valuable, may 
not represent the in vivo environment. Utilizing additive manufacturing technologies, 





trophoblast-laden placenta model with micro-patterned biomaterials (Figure 3.4a). 
The ability to pattern cells and chemoattractant was crucial because it enabled the 
quantifications of cell invasion rates (demonstrated in Figure 3.4b) rather than the 
binary read-outs in current conventional 2D invasion assays (e.g. transwell). In vitro 
culture using pECM supports adhesion, proliferation and invasion of trophoblasts for 
at least 7 days. Altogether, we demonstrated that bioprinting with tissue-specific 
ECM is an attractive option for constructing in vitro placental tissue model to screen 
for novel therapeutics for placental diseases and their pathology. Our tissue specific, 
bioprinted placental model can potentially predict in vivo drug administration 
outcome for PE. Furthermore, other tissue models such as cancer can be developed 
based on the method presented in this work by recreating the key microenvironmental 
characteristics (complex ECM composition, mechanical properties, cellularity) that 
are representative to the in vivo environment.  
3.5 Conclusion 
We successfully incorporated placental BM protein (pECM) isolated from 
human placenta in our established bioprinting platform. Our results showed that 
pECM significantly increased adhesion, proliferation, and invasion of trophoblasts 
and these effects could not be reproduced using fractions of pECM. Particularly, the 
addition of pECM was required for trophoblasts to achieve effective invasion rates 
that is comparable normal pregnancies and PI3K appear to play a dominant role in 
this process. Our results illustrated, for the first time, the significant effects of the 
ECM microenvironment in trophoblast invasion, a parameter that is less investigated 





bioprinting organ models with organ-specific ECM can be used to screen for novel 





Chapter 4:  Interstitial Flow and Trophoblast Regulate 
Angiogenic Responses and Phenotypes in a 3D Bioprinted 
Placenta Model 
4.1 Introduction 
Tissues are composed of cells and extracellular matrix (ECM) that is filled 
with interstitial fluid [179]. Physiological processes such as muscle contractions can 
cause fluid flow within the ECM, which is defined as interstitial flow [179]. 
Interstitial flow causes fluid shear stress, defined as frictional force exerted by 
moving fluids on the surrounding wall, which is a key regulator for maintaining 
proper endothelium function [70, 180, 181]. Recently, studies have shown interstitial 
flow can induce shear stress in a hydrogel scaffold with significant biological effects 
on the cells encapsulated in the hydrogel [70, 182, 183]. However, the effect of 
interstitial shear stress on the angiogenesis (the development of new blood vessels 
from existing ones [67]) of endothelial cells (EC) is rarely investigated. Angiogenesis 
typically involves proliferation, upregulations of matrix metalloproteinase (a class of 
enzymes that degrades the extracellular matrix), and invasion/migration of endothelial 
cells [67]. In adults, angiogenesis seldom occurs except in would healing, 
pathological conditions (e.g. tumor growth), or endometrium growth during menstrual 
cycle/pregnancy [67]. 
Interstitial flow can arise from uterine contractile activities that are important 
for proper embryo implantation and pregnancy success [184]. Improper implantation 





morbidity and mortality, affecting 3 to 8% of all pregnancies [107]. Globally, about 
76,000 pregnant women and 500,000 infants are dying from PE and related 
hypertensive disorders [186]. Preeclampsia is characterized by intense systemic 
vasoconstriction leading to maternal hypertension, a clinical hallmark for 
preeclampsia [187]. Some of the early evidences of systemic endothelial dysfunction 
in preeclampsia came from measurement of plasma biomarkers of endothelial cell 
activation including von Willebrand factor [188], plasma cellular fibronectin [189], 
thrombomodulin [190], endothelin-1 (ET-1) [191, 192], and soluble fms-like tyrosine 
kinase (sFlt-1) [193]. These findings indicate that endothelial dysfunction plays a 
central role in preeclampsia, but the underlying mechanism is unclear [193]. One 
theory suggests that the microparticles secreted by trophoblast could be a major 
contributor [194, 195]. However, the effects of trophoblasts on the flow-induced 
remodeling of endothelial cells are unknown. This is, in part, because current in vitro 
placenta models are not equipped to simultaneously manipulate of fluid shear stress 
and cellularity.  
In this work, we presented a robust platform to address this challenge using 
3D printing and a perfusion based bioreactor. Our hypothesis was that interstitial flow 
induces angiogenic responses of endothelial cells and these responses are reduced in 
the presence of trophoblasts. We started by designing a cylindrical placenta model 
(diameter=10 mm; height=2 mm) with an patent central lumen (diameter = 1 mm) to 
model a major human artery (1-2 mm in diameter [196]). Customized bioreactor 
chambers were 3D printed to fit the bioprinted placenta model and connected to a 





characterized in vitro and in silico. Next, we bioprinted the 3D placenta model with 
endothelial cells homogenously distributed, and perfused through the lumen. We 
found that the flow could only affect endothelial cells that were less than 400 µm 
away from the lumen. Increasing shear stress led to higher angiogenic responses of 
endothelia cells, which were significantly impaired in the presence of trophoblast. 
These results demonstrated, for the first time, that the position of endothelial cells 
within a bioprinted hydrogel scaffold influenced their angiogenic responses and 
phenotypes. Moreover, fluid flow significantly augmented the angiogenic outgrowth 
and responses of endothelial cells, which were impaired by the presence of 
trophoblasts, providing a cellular mechanism for the systemic endothelial dysfunction 
observed in PE. Our strategy that generated neovascularized placenta model with 
spatially-defined heterogenous cellularity is a physiologically relevant tool for 














4.2 Materials and Methods 
Cell Culture 
Human Umbilical Vein Endothelial Cells (HUVEC) were purchased from 
Lonza, cultured in Endothelial Growth Medium Bullet Kits (EGM BulletKit; Lonza) 
according to manufacturer’s instructions, and used until P5. HTR8 cells, an 
extravillous trophoblast cell line, were purchased from ATCC and cultured according 
to manufacturer’s instructions. For coculture experiments, bioprinted placenta model 
were cultured in complete endothelial growth medium. 
 
Gelatin Methacrylate Synthesis 
Gelatin methacrylate was synthesized according to previously published 
methods [5, 78].  Briefly, type A porcine skin gelatin (Sigma-Aldrich; 300 bloom) 
was mixed at 10% (w/v) in phosphate buffered saline (PBS; Thermo Fisher 
Scientific) at 50 oC for 20 minutes. Methacrylic anhydride (MA, Sigma-Aldrich) was 
then added at 0.6 g of MA / g gelatin under rigorous stirring for an hour. The 
reactants were then diluted 2x with PBS to stop the reaction. The mixture was 
centrifuged, and the pellet was discarded. The supernatant was dialyzed against 
deionized water at 50°C using dialysis cassettes (10kDa MWCO, Thermo Fisher 
Scientific) for at least 3 days. The deionized water was changed twice a day to 
remove salts and excess methacrylic acid. The dialyzed GelMA was then lyophilized 







Bioprinting Placenta Model 
The placenta model is a cylindrical construct (height = 2 mm; diameter = 10 
mm) with different biomaterials in the radial directions. All bioprinting work was 
completed using a commercial 3D bioprinter (3D-Bioplotter; EnvisionTEC). To 
prepare the prepolymer solution, lyophilized GelMA was dissolved in complete 
growth media at 50°C for 20 minutes. Photoinitiator (2-hydroxy-1-(4-
(hydroxyethoxy)phenyl)-2-methyl-1-propanone; Irgacure 2959; BASF) was then 
added into the GelMA solution at 0.1% (w/v) at 50°C for 15 minutes. The prepolymer 
solution was loaded into the low-temperature printer head and allowed to equilibrate 
for 20 minutes at 37°C. Fibronectin (50 µg/mL), Human Umbilical Vein Endothelial 
Cells (HUVEC, 10 million/mL), and/or a trophoblast cell line (HTR8, 2 million/mL) 
were then added. The final enriched prepolymer solutions were then loaded into 
printing cartridge and allowed to equilibrate to printing temperature (20-21°C) for 
another 30 minutes prior to printing. Printed constructs were UV-cured for 30 
seconds (0.09 mW/cm2) using a UV box (VWR).  
 
3D Printing of the Bioreactor Chamber 
The bioreactor was designed using Solidworks 3D CAD software (Dassault 
Systèmes SolidWorks Corporation). The bioreactor is composed of two halves that 
form a single chamber when assembled together. Both halves of the bioreactor are 
separated by a biocompatible Viton Fluroelastomer O-ring (McMaster Carr) to ensure 
a leak free seal when assembled. The CAD model was exported as a binary 





angular tolerance of 10 deg was chosen to preserve resolution during fabrication. The 
bioreactor was fabricated using the Connex500 3D printer (Stratasys) with Med610 
polyjet material. Med610 was chosen for its biocompatibility to ensure the bioreactor 
did not adversely affect the soft tissue model. After 3D printing, the bioreactors were 
cleaned with water and sodium hydroxide, and then disinfected with an isopropyl 
bath per the manufacture’s guidelines for Med610. 
 
Perfusion Bioreactor System 
The perfusion bioreactor system was assembled as described previously [111, 
117, 118, 197] and illustrated in Figure 1d. Bioprinted placenta models were loaded 
into 3D printed bioreactor chamber (Figure 1f) and connected to the perfusion based 
bioreactor. The cell culture media was driven by an L/S Multichannel Pump System 
(Cole Parmer, Vernon Hills, IL) at controlled flow rates and cultured for 3 days. At 
the end of the study, bioprinted cells were isolated from GelMA scaffolds by 
dissolution in papain (4 mg/mL) for 30 min at 37o C. A cell pellet was formed by 
centrifugation and used for downstream analysis.   
 
Computational Fluid Dynamics (CFD) 
The diffusion models developed in this study was generated using COMSOL 
assuming 1D radial diffusion in cylindrical coordinates. For diffusion of oxygen, we 
assumed a perfect source from the center of the disc and a no flux condition at the 
edge of the disc.  For diffusion of biomolecules secreted from trophoblasts, we used 





tissue model where trophoblasts were bioprinted and a perfect sink condition along 
the center lumen where endothelial cells were resided. The diffusion coefficient of 
oxygen [143] and epidermal growth factor [5] as the model biomolecule in GelMA 
was obtained from the literatures. Diffusion model were set up as described in chapter 
2. 
 
RNA Isolation and qRT-PCR 
Cell pellets were dissolved in Trizol (Thermo Fisher Scientific). Total RNA 
was using the RNeasy Plus Mini Kit (Qiagen) and then reverse transcribed to 
complementary DNA (cDNA) using a High Capacity cDNA Archive Kit (Thermo 
Fisher Scientific).  Quantitative reverse transcriptase-polymerase chain reaction 
(qRT-PCR) was performed by combining the cDNA solution with a Universal Master 
Mix (Thermo Fisher Scientific), as well as oligonucleotide primers and Taqman 
probes for MMP2, MMP9 and the endogenous gene control glyceraldehyde-3-
phosphate dehydrogenase (GAPDH; Thermo Fisher Scientific). The reaction was 
performed using a 7900HT real-time PCR System (Applied Biosystems) at thermal 
conditions of 2 min at 50°C, 10 min at 95°C, 40 cycles of 15 s at 95°C, and 1 min at 
60°C. The relative gene expression level of each target gene was normalized to the 
mean of GAPDH in each group then the fold change was determined relative to 
appropriate controls. Fold change was calculated using the ΔΔCT relative 








For the invasion experiments, phase-contrast images were taken on day 1 and 
day 3. The distance between the periphery of the inner lumen of the soft tissue model 
and the invasion fronts of endothelial cells were measured and averaged over time to 
obtain invasion rates, as described previously [5, 78].   
 
Immunofluorescence staining and Quantitative Image Analysis 
Bioprinted, cell-laden GelMA hydrogels were fixed in 3.7% formaldehyde 
solution for 15 minutes and permeabilized with 0.3% Triton X-100 for 5 min. 
Hydrogels were blocked by 5% bovine serum albumin (BSA) solution for 30 min and 
incubated overnight with primary antibody (mouse anti-human CD31; 1:100 dilution; 
R&D systems). The stained HUVECs were observed with a fluorescent microscope. 
The endothelial cells were characterized for number of linear aggregates/area, length 
of aggregates, fraction of area covered by network of endothelial cells, and number of 
branching points/area using Image J [198]. At least 3 samples for each condition were 
processed for analysis. 
 
Statistical Analysis 
Error bars were expressed as standard deviation (SD) and * indicated 
statistically significant differences between groups. Data from all the studies were 
analyzed using student’s t-test and/or analysis of variance (ANCOVA) using Minitab. 







4.3.1 Development and Characterization of a Customized Perfusion based 
Bioreactor System 
Previous studies have demonstrated that interstitial flow can be generated in 
vitro near the surface of the hydrogels expositing to a parallel fluid flow [182]. In the 
present work, we leveraged the advantages of 3D printing to fabricate customized 
chambers to fit bioprinted placenta models based on a perfusion based bioreactor 
(Figure 4.1a,d) [5, 116]. We also fabricated a rack to hold the bioreactor chambers in 
place to ensure the directions of media flow and gravitational forces were uniform 
between samples. Next, the resulting fluid shear stress profile for the placenta model 
was calculated through computational fluid dynamics (Figure 4.1b). We found that 
the fluid shear stress could be controlled by adjusting the flow velocity, and the 
resulting shear stress values were in the physiologically relevant regime (Figure 
4.1c). To ensure the nutrients could diffuse radially outwards in the bioprinted 
placenta model from the central lumen, we used a blue dye to observe the diffusion 
characteristics qualitatively. As shown in Figure 4.1e, the central lumen (red arrow) 
was patent and visible (top two images; d = 1 mm) at t = 0. After two hours of 
perfusion, limited radial diffusion was observed from the central lumen while the 
bulk of the 3D printed gel remained translucent. After 12 hours of perfusion, there 
were significant radial diffusion of the blue dye (Figure 4.1e). Computational fluid 
dynamics was utilized to quantitatively assess the mass transport of nutrients within 
the bioprinted placenta model. Using oxygen as a model nutrient, we found that there 





of dynamic culture, computational model predicted the nutrient would diffuse equally 





















Figure 4.1. Development 3D Printed Perfusion Bioreactor System for the 
Bioprinted Placenta Model. (a) Computer-aided design (CAD) for customized 
bioreactor chamber. (b) Characterization of interfacial fluid shear stress. Flow was 
perfused through the center lumen of the bioreactor chamber (left) which induced 
shear stress along the wall. The wall shear stress was calculated by computational 
fluid dynamics (CFD, right). (c) Fluid shear stress as a function of flow velocity. CFD 
demonstrated a linear relationship between fluid shear stress and velocity in the 
physiologically relevant range (R2 = 0.99). (d) Illustration of 3D printed tubular 
perfusion system. The perfusion system was driven by a peristaltic pump (bottom) 
that pushed the media from the media reservoirs through the 3D printed bioreactor 
chambers. The media was then returned to the media reservoir to complete the 
circulation. The entire system was housed in a cell culture incubator with temperature 
and humidity control. (e) Concentration profile of oxygen in the bioprinted placenta 
model. Computational fluid dynamic predicted that oxygen concentration would 
reach equilibrium by 11 hours. (f) Qualitative images of bioprinted placenta model. 
The picture on the top left demonstrated where the placenta model would be housed 
relative to the 3D printed reactor chamber, and was enlarged in the picture on the 
right. The bioprinted placenta model had a cylindrical shape (diameter = 10 mm; 
height = 2 mm) with a patent channel at the center (red arrow). Using a blue dye, we 
demonstrated that material diffused radially outwards from the central lumen after 12 






 4.3.2 Position of Endothelial Cells Influences their Proliferation and 
Angiogenesis  
To determine effect of position on angiogenesis of endothelial cells, we 
bioprinted placenta models that had endothelial cells homogenously distributed. Then 
we divided the bioprinted placenta model into 3 zones according to their distances 
from the central lumen for quantitative image analysis (I = 0-200 µm, II = 200-400 
µm, and III = 400-600 µm; Figure 4.2a). Fluorescent intensity (FI, normalized to the 
brightest reading in each zone) of DAPI, which correlated with number of cells, 
decreased as distance from the central lumen increased (I=0.92±0.08; II=0.77±0.11; 
III=0.66±0.15). This was not surprising because fluid shear stress is known to induce 
endothelial cells proliferation [180]. Similarly, angiogenic responses measured by 
network formation of endothelial cells also significantly decreased as distance from 
the central lumen increased (Figure 4.2c,d; number of linear aggregates 
(I=92.67±37.69, II=50.68±22.92, III=8.61±5.51 tubules/mm2) and fraction of area 
covered by EC networks (I=7.9±2.81, II=4.32±0.94, III=0.74±0.92 %)). Altogether, 
we found that the angiogenic effects of flow significantly reduced for endothelial 
cells that were more than 400 µm away from lumen. Therefore, analysis for the rest 
of the work focused on endothelial cells that were within 400 µm measured from the 









Figure 4.2 Position of Endothelial Cells Influenced Proliferation and 
Angiogenesis during Dynamic Culture. (a) Representative of bioprinted endothelial 
cells with DAPI Staining. The bioprinted placenta model was divided into 3 zones 
according to their distance from the central lumen (I = 0-200 µm, II = 200-400 µm, 
and III = 400-800 µm) for quantitative image analysis (scale bar = 200 µm). (b) 
Fluorescent intensity (FI) of DAPI as a function of position. Average DAPI FI, which 
correlated with the number of cells, was measured. The FI decreased as the distance 
from the central channel increased (n = 3). (c) Number of linear aggregates as a 
function of position. The number of linear aggregates/area decreased as the distance 
away from the central channel increased (n = 3). (d) Fraction of area covered by EC 
network. The fraction of area covered by EC network decreased as distance from 
central channel increased (n = 3). Error bars represented standard deviation and * 






4.3.3 Dosage-Dependent Effects of Shear Stress on Angiogenesis and 
Outgrowth of Endothelial Cells 
It is widely accepted that fluid shear stress promotes angiogenic response of 
endothelial cells but the impact of interstitial flow in endothelial cells remain poorly 
understood. To investigate the effect of interstitial flow in angiogenesis, a layer of 
endothelial cells (<400 µm wide) were bioprinted along the periphery of the central 
lumen in the placenta model. After 3 days of perfusion, the angiogenic responses of 
endothelial cells were assessed and compared against static control. Representative 
images in Figure 4.3a,c,b showed a dosage-dependent response of network 
formations (demonstrated by multiple nuclei stains) in the dynamic culture groups 
while the static control group remain their circular morphology. Quantitative image 
analysis demonstrated a significant (p<0.05) dosage-dependent angiogenic responses 
of endothelial cells, measured by network formation, towards interfacial shear 
stresses based on length of aggregates, number of linear aggregates/area, fraction of 
area covered by EC network, and number of branching points/area (Figure 4.3d-g). 
Normalized fluorescent intensity (FI) of CD31 of endothelial cells (a marker for 
angiogenesis [199]) also appeared to be positively correlated with shear stress 
(static=1±0.001, 0.1 dyne/cm2=2.43±0.01 and 1 dyne/cm2=2.84 ±0.02; p<0.05; 













Figure 4.3. Fluid Shear Stress Augmented In Vitro Angiogenesis of Endothelial 
Cells. (a) Representative fluorescent images of EC in static culture. After 3 days of 
static culture, cells remained circular (blue = nuclei; green = CD31; scale bar = 100 
µm). (b) Representative fluorescent images of EC under 0.1 dyne/cm2 of interfacial 
shear stress. Limited network formation of EC occurred after 3 days of dynamic 
culture (blue = nuclei; green = CD31; scale bar = 100 µm). (c) Representative 
fluorescent images of EC under 1 dyne/cm2 of interfacial shear stress. Significant 
network formation of EC occurred after 3 days of dynamic culture (blue = nuclei; 
green = CD31; scale bar = 100 µm).  (d-g) Quantitative image analysis to determine 
EC network formation. Interstitial flow induced angiogenic response of EC in a 
dosage dependent-manner by increasing the number, length, and area of the linear 
aggregates, as well as the number of branching points (n = 3). Error bars represented 














Figure 4.4. CD31 Staining of Endothelial Cells was Enhanced by Fluid Shear 
Stress. (a) Representative image of fluorescent staining for CD31 in static culture 
(scale bar = 100 µm). (b) Representative image of fluorescent staining for CD31 
under 0.1 dyne/cm2 of interfacial shear stress (scale bar = 100 µm). (c) Representative 
image of fluorescent staining for CD31 under 1 dyne/cm2 of interfacial shear stress 
(scale bar = 100 µm). (d) Fluorescent intensity of CD31. Fluid shear stress enhanced 
fluorescent intensity of CD31 in a dosage-dependent manner (n = 3). Error bars 












In addition to network formation and CD31 staining, another key angiogenic 
phenotypes are the migration/outgrowth of endothelial cells [198]. Bright field 
images showed interfacial shear stress at 1 dyne/cm2 induced invasion of endothelial 
cells compare to static control (Figure 4.5a,b) with significant differences in the 
outgrowth rates (static=14.10±2.30 µm/day, dynamic=31.88±7.48 µm/day; p<0.05; 
Figure 4.5c). Gene expressions of invasion and angiogenic markers such as MMP2 
(static=1±0.06, dynamic=2.74±0.12; p<0.05), MMP9 (static=1±0.05, 
dynamic=17.18±4.03; p<0.05), and VEGFA (static=1±0.06, dynamic=1.75±0.08; 
p<0.05) were all significantly upregulated when exposed to interstitial fluid shear 
stress (Figure 4.5d-f). The significant upregulation of VEGFA suggest the interstitial 



















Figure 4.5. Fluid Shear Stress Promoted Outgrowth of Endothelial Cells. (a) 
Representative image of placenta model under static culture. After 3 days of static 
culture, endothelial cells remained circular with limited outgrowth (scale bar = 500 
µm). (b) Representative image of dynamic culture. Outgrowth of endothelial cells 
occurred in the direction of interstitial flow (yellow arrow) with extensive network 
formation after 3 days of dynamic culture (scale bar = 500 µm). (c) Outgrowth rates 
of endothelial cells. Interstitial flow enhanced endothelial cells outgrowth rates 
significantly (n = 3). Interstitial flow significantly increased gene expressions of 
angiogenic markers such as (d) MMP2 (n = 3), (e) MMP9 (n = 3), and (f) VEGFA (n 
= 3). Error bars represented standard deviation and * indicated significant difference 











4.3.4 Flow-Induced Endothelial Cells Outgrowth and Angiogenesis were 
Impaired by Trophoblasts  
Once we have determined the angiogenic responses of endothelial cells in the 
customized perfusion bioreactor system, we used it to test endothelium-trophoblast 
interactions, a crucial process in placental development and preeclampsia [6, 107, 
200, 201]. Utilizing the advantages of bioprinting, we patterned a ring of trophoblasts 
(green in Figure 4.6a) that was relatively far away from the endothelial cells (<4 
mm). Endothelial cells remained along the periphery of the inner lumen (red in 
Figure 4.6a). Shear stress was maintained at 1 dyne/cm2, which was similar to what 
is observed in vivo [196]. Compare to controls, the endothelial cells invaded less and 
had less network formation in the presence of trophoblasts (Figure 4.6b,c). 
Quantitative image analysis showed the outgrowth rate of endothelial cells was 
significantly impaired by the presence of trophoblasts (Trophoblast (+) = 1.82±7.11 
µm/day, Trophoblast (-) = 30.47±5.99 µm/day; Figure 4.6d; p<0.05). On the other 
hand, presence of endothelial cells reduced the invasion rates of trophoblasts 
significantly (Figure 4.6e). Further analysis demonstrated that the presence of 
trophoblasts reduced the length of aggregates of endothelial cells in Figure 4.7a,b 
(Trophoblast (+) = 14.03 ± 4.32 x1000µm/mm2, Trophoblast (-) = 27.11±1.77 
x1000µm/mm2; p<0.05) and number of linear aggregates (Trophoblast (+) = 
401.14±122.02 /mm2, trophoblast (-) = 558.18±115.42 tubules/mm2; p>0.05). 
Moreover, the presence of trophoblasts significantly reduced the fraction that are 
covered by EC network (Trophoblast (+) = 0.095 ± 0.024, Trophoblast (-) = 





152.33±31.12/mm2, Trophoblast (-) = 305.05±25.06/mm2; p<0.05). Since there was a 
relatively large distance between endothelial cells and trophoblasts, the reduced 
outgrowth rates were most likely due to the biomolecules secreted by the 
trophoblasts. Computational fluid dynamic predicted that the biomolecules secreted 
by trophoblasts, using EGF as a model, would diffuse to the endothelial cells and 
reached a physiologically relevant concentration (>100 nM) by day 1 (Figure 4.7e,f). 
Taken together, these results showed the presence of trophoblasts impaired the 
















Figure 4.6. Interactions between Trophoblasts on Endothelial Cells. (a) 
Representative fluorescent images of bioprinted placenta model to determine 
endothelium-trophoblasts interactions. Endothelial cells (red) were bioprinted along 
the inner periphery of the inner lumen while trophoblasts (green) were bioprinted 
along the outer periphery (scale bar = 500 µm). (b) Representative bright field image 
of endothelial cells with trophoblasts (scale bar = 500 µm). (c) Representative bright 
field image of endothelial cells without trophoblast (scale bar = 500 µm). (d) 
Outgrowth rates of endothelial cells. The presence of trophoblasts significantly 
impaired the outgrowth rates of endothelial cells compare to control (n = 3). (e) 
Invasion rates of trophoblasts as a function of endothelial cells. The presence of 
endothelial cells significantly reduced the invasion rates of trophoblasts (n = 3). Error 
bars represented standard deviation and * indicated significant difference between 

















Figure 4.7. Effect of Trophoblasts on Angiogenesis of Endothelial Cells In Vitro. 
Quantitative image analysis indicated the presence of trophoblast impaired 
angiogenic phenotypes of endothelial cells such as (a) Length of aggregates/area (n = 
3), (b) Number of linear aggregates/area (n = 3), (c) Fraction of area covered by EC 
network (n = 3), and (d) Number of branching points/area (n = 3). (e) Diffusion 
profile of EGF as our model biomolecule secreted from trophoblasts (outer ring in 
green with black outline) towards endothelial cells (inner ring in red with black 
outline) by computational fluid dynamics. (f) Local concentration profile of EGF 
secreted by trophoblasts at the position of endothelial cells (400 µm away from the 
lumen). Error bars represented standard deviation and * indicated significant 






















The goal of this research was to determine the effect of interstitial flow and 
trophoblast on the angiogenic response and phenotypes of endothelial cells. 
Leveraging the advantages of 3D printing and perfusion based bioreactor, we 
developed a robust experimental platform that could apply stable and controlled fluid 
shear stress in a 3D bioprinted placenta model. Flow stimulation led to a dosage-
dependent increase of angiogenic and proliferative responses of endothelial cells in 
regions near the perfused lumen (<400 µm). The shear stress-induced angiogenic 
response of endothelial cells was impaired in the presence of trophoblasts.  
Previous studies have demonstrated interstitial flow can occur by applying an 
interfacial flow parallel to the surface of a hydrogel [70, 182, 183]. Chen et al. 
characterized the interstitial flow fields based on the fluorescence recovery after 
photobleaching technique and found the effect of interstitial flow (e.g. shear stress 
and convective diffusion) become negligible at depths beyond 50 micrometers [182]. 
However, the system used by Chen et al. was acellular and significantly smaller 
(lumen diameter=200 µm; thickness=100 µm), while our system was cell-laden and 
orders-of-magnitude larger (lumen diameter=1000 µm and thickness=5000 µm). The 
depth influenced by interstitial flow in the larger system should scale-up in proportion 
[182], which explain the deeper region (200-400 µm) of enhanced proliferation and 
network formation of EC observed in our study. Additionally, gradients of soluble 
factors created from the enhanced transport and mechanotransduction from the 
interstitial flow may lead to paracrine signaling effects that extend beyond that layer 





Endothelium plays a central role in preeclampsia that is characterized by 
systemic maternal hypertension and intense vasoconstriction [67]. While the 
underlying mechanism of this endothelium dysfunction is unclear, one theory 
suggested that the microparticles secreted by trophoblast could be a major contributor 
[194, 195]. Specifically, Sargent et al. showed that a higher concentration of 
trophoblast-derived microparticles in women with preeclampsia [194]. However, the 
effect of trophoblasts on angiogenesis of endothelial cells, a process that is critical in 
successful implantation, remain to be elucidated. In this research, we showed the 
presence of trophoblast reduced the angiogenic response of endothelial cells. The 
spatial arrangement of cells suggested the reduced angiogenesis was most likely due 
to the diffusion biomolecules from trophoblasts to the endothelial cells, a first piece 
of in vitro support for the theory proposed by Sargent et al. Interestingly, the presence 
of endothelial cells seem to reduce trophoblast invasion rates. This implied the 
invasion of trophoblast is likely to be driven by chemokines secreted from the 
maternal circulation [42] rather than signals produced directly from endothelial cells. 
Overall, our results propose a novel cellular mechanism for endothelium dysfunctions 
observed in preeclampsia. 
The creation of vascularized engineered tissues of clinically relevant size has 
been a major challenge in tissue engineering [202]. Recent advances in 
bioengineering have led to the development of complex experimental platforms to 
model angiogenesis of endothelial cells in response to fluid shear stress [70]. 
However, these existing experimental platforms are often in micron-scale, which may 





engineering is vascularization upon implantation [202], which are typically in 
millimeter-centimeter scale [203]. Scaling up from micrometer scale system to 
human-sized scale can be problematic [119]. Moreover, biological processes 
involving cells-ECM-growth factors may take place in millimeter-centimeter scale 
(e.g. trophoblast invasion penetrates 5 mm thick layer of tissue in vivo [173]). In this 
work, we found that the interstitial flow induced by tubular perfusion system induced 
network formation that covered 51.6±1% of the soft tissue model by volume. The 
heterogeneous effect of the interstitial flow on the cells encapsulated in bioprinted 
hydrogel was defined, which would be an important parameter to consider for 
engineering complex tissues. Moreover, this platform provided an effective tool to 
study angiogenic response and migration of endothelial cells to controlled flow and/or 
other microenvironmental factors. Using 3D bioprinting, multiple biomaterials (e.g. 
cells and growth factors) can be easily deposited simultaneously to define the 
mechanism governing the angiogenesis of endothelial cells. Our approach of 
leveraging 3D printing and perfusion based bioreactor to create a heterogenous and 
pre-vascularized hydrogel in millimeter-centimeter scale served as a step towards 
fabricating relevant tissue engineered constructs for regenerative medicine, drug 
discovery, and mechanistic study. 
4.5 Conclusion 
In this work, a robust platform that generated neovascularized, complex 
placenta model in millimeter-centimeter scale was presented. Through cell patterning 
and a customized perfusion based bioreactor, we found the position of endothelial 





Interstitial flow alone led to orders-of-magnitude increase in angiogenic responses of 
endothelial cells in a dosage-dependent manner. This enhanced angiogenesis was 
impaired in the presence of trophoblast, suggesting a cellular mechanism of the 
systemic endothelial dysfunction observed in preeclampsia. Our versatile approach 
can generate heterogenous, pre-neovascularized placenta model for developing novel 







Chapter 5:  Summary and Future Directions 
5.1 Summary 
The goal of this work was to determine the role of cellular microenvironment 
in preeclampsia, a leading cause of maternal and perinatal morbidity and mortality. 
Utilizing the capabilities of 3D bioprinting and shear wave elastography, we first 
developed a bioprinted placenta model to study and quantify trophoblast migration, 
which is presented in chapter 2 of this work. Using the bioprinted placenta model, we 
established a positive correlation between of epidermal growth factor (EGF) and 
migration rates of trophoblasts. These results indicate a feasible ex vivo placental 
model can be bioprinted to examine cellular, molecular and pharmacologic 
interactions.  
Once we have established the bioprinted placenta model, we wanted to 
determine the effect of extracellular matrix composition on trophoblast invasion, 
which was summarized in chapter 3. From the literature we learned the placental 
basement membrane proteins (e.g. laminin, collagen) has been implicated in the 
development of placenta while the level of laminin is significantly lower in 
preeclampsia. We isolated extracellular matrix material from term placenta and found 
that 80% of its peptides were BM proteins. These basement membrane proteins 
upregulated expressions of MMP2 and MMP9 and increased the motility rates of 
trophoblasts by 13-fold to achieve an effective invasion rate that was comparable to 
in vivo results. Treatments with PI3K inhibitors completely removed the pECM-
enhanced invasive phenotypes and genotypes of trophoblasts, suggesting its dominant 





substantial effects of the extracellular matrix on regulating trophoblast invasion, an 
area that is less investigated but appear to be critical in the pathogenesis of 
preeclampsia.  
Finally, in chapter 4, we use the perfusion based bioreactor system to place 
the placenta model under fluid flow to determine the effect of trophoblast on 
placental angiogenesis. Clinically, preeclampsia is characterized by systemic maternal 
endothelial dysfunction. Biomolecules secreted by trophoblast was proposed to be a 
mechanism for the systemic endothelial dysfunction in preeclampsia but their effect 
on the angiogenesis of endothelial cells is unclear, partly due to a lack of suitable 
experimental tools. In the last part of the experimental work, we improved the 
bioprinted placenta model by developing a customized perfusion bioreactor system 
that addressed this challenge. The diffusion and shear stress profile for the perfusion 
bioreactor system were characterized by computational fluid dynamics. We found 
interstitial flow could enhance angiogenic responses of endothelia cells, demonstrated 
by orders of magnitude increase in network formations, significantly increased 
outgrowth rates, and upregulation of angiogenic-associated genes. Presence of 
trophoblast impaired these interstitial flow-enhanced angiogenic responses and 
outgrowth of endothelial cells, suggesting a cellular mechanism for the systemic 
endothelial dysfunction observed in preeclampsia.  
In conclusion, we have introduced, for the first time, the decidual ECM 
compositions and trophoblast-EC interactions as potential pathologies for 
preeclampsia. Specifically, the critical role of placental basement membrane protein 





for diagnosing and predicting preeclampsia. Moreover, trophoblast significantly 
impaired the angiogenic responses of endothelial cells, indicating their potential roles 
in the systemic endothelium dysfunction. Taken broadly, our bioprinted placenta 
model is a safe, physiologically relevant, and high throughput tool to screen and 
develop the much-needed therapeutics, biomarkers, and predictors for preeclampsia.  
5.2 Proposed Future Work  
In this work, we have described significant roles of extracellular matrix 
composition and fluid flow in preeclampsia, but there are certainly other important 
questions related to preeclampsia that can to be answered using our bioprinted 
placenta model as future work. 
 One interesting study would involve isolating primary biomaterials (e.g. 
trophoblast and extracellular matrix) from normal and preeclamptic pregnancies to 
answer a fundamental question in the mechanism of preeclampsia: is the impaired 
trophoblast invasion in preeclampsia due to the extrinsic properties of the maternal 
decidual microenvironment or is it due to the intrinsic properties of the fetal 
trophoblasts? This question has been debated among investigators in the field of 
placental biology [204] and we have developed a tool that can be used to find the 
answer. Specifically, we could use trophoblasts isolated from preeclamptic placenta 
and test their invasion rates in 3D placenta model containing either extracellular 
matrix isolated from normal or preeclamptic placenta. Assuming the impaired 
trophoblast invasion is due to the cells’ intrinsic properties, we should expect to 
similar invasion rates regardless of the different placental ECM isolated from normal 





trophoblast isolated from normal pregnancies. Results from these experiments would 
provide some insights into the relative contributions of fetal trophoblast and maternal 
decidual microenvironments in preeclampsia.  
Another study that would be worth pursing is to test the effect of shear stress 
on spiral arteries remodeling. It is well-established that during decidualization, the 
spiral arteries remodel and dilate slightly prior to the arrival of trophoblast [18]. 
However, the effect of these trophoblast-independent remodeling on the later 
trophoblast-dependent remodeling of spiral arteries is unclear. Our perfusion based 
bioreactor system uniquely permits the investigation on the effect of changing shear 
stress, resulting from trophoblast-independent remodeling, on the trophoblasts-
mediated remodeling of the endothelial cells. Results from these experiments would 
shine lights on the importance of decidualization on trophoblast remodeling of the 
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